Delaware |
6 199 |
86-1481509 | ||
(State or Other Jurisdiction of Incorporation or Organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification Number) |
Josh Pollick, Esq. Albert W. Vanderlaan, Esq. Orrick Herrington & Sutcliffe LLP 631 Wilshire Boulevard, Suite 2-C Santa Monica, CA 90401 Tel: (310) 633-2800 |
John Ricci General Counsel 1265 South Cochran Avenue Los Angeles, CA 90019 Tel: (844) 857-3283 |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ | Smaller reporting company | |||||
Emerging growth company |
Page |
||||
1 | ||||
2 | ||||
6 | ||||
8 | ||||
14 | ||||
42 | ||||
43 | ||||
44 | ||||
45 | ||||
47 | ||||
52 | ||||
54 | ||||
56 | ||||
62 | ||||
85 | ||||
101 | ||||
107 | ||||
126 | ||||
131 | ||||
133 | ||||
137 | ||||
143 | ||||
144 | ||||
147 | ||||
154 | ||||
154 | ||||
154 | ||||
F-1 |
• | “Business Combination” are to the Merger Agreement and the transactions contemplated by the Merger Agreement, which include the Mergers and the other transactions contemplated thereby; |
• | “Business Combination Shares” are to the shares of Dave Class A Common Stock issued upon consummation of the Business Combination pursuant to the Merger Agreement and held by certain of Dave’s officers, directors and greater than 5% stockholders and their affiliated entities; |
• | “Closing” are to January 5, 2022, the date of the consummation of the Business Combination; |
• | “Closing Date” are to the date the Closing takes place; |
• | “Code” are to the U.S. Internal Revenue Code of 1986, as amended; |
• | “Conversion” are to the conversion of each share of Legacy Dave Class A Common Stock held by Jason Wilk into the same number of shares of Legacy Dave Class V Common Stock immediately prior to the Effective Time at the then-effective conversion rate; |
• | “Common Stock” are to the Dave Class A Common Stock and Dave Class V Common Stock; |
• | “Dave” are to Dave Inc., a Delaware corporation, which prior to the Business Combination was known as VPC Impact Acquisition Holdings III, Inc., a Delaware corporation; |
• | “Board” are to the board of directors of Dave; |
• | “Dave Bylaws” are to the Amended and Restated Bylaws of Dave dated January 5, 2022, as the same may be amended, supplemented or modified from time to time; |
• | “Dave Charter” are to the Second Amended and Restated Certificate of Incorporation of Dave dated January 5, 2022, as the same may be amended, supplemented or modified from time to time; |
• | “Dave Class A Common Stock” are to the shares of Class A common stock, par value $0.0001 per share, of Dave; |
• | “Dave Class V Common Stock” are to the shares of Class V common stock, par value $0.0001 per share, of Dave; |
• | “Dave Warrants” are to Public Warrants and Private Warrants; |
• | “DGCL” are to the Delaware General Corporation Law; |
• | “Legacy Dave Stockholders” are the holders of Legacy Dave Capital Stock as of immediately prior to the Closing; |
• | “Effective Time” are to the date and time at which the First Merger became effective; |
• | “First Merger” are to the merger of First Merger Sub with and into Legacy Dave, with Legacy Dave surviving the merger as a wholly owned subsidiary of VPCC; |
• | “First Merger Sub” are to Bear Merger Company I Inc., a Delaware corporation and direct, wholly owned subsidiary of VPCC; |
• | “Founder Holder Agreement” are to that certain Founder Holder Agreement, dated as of June 7, 2021, by and among VPCC, the Founder Holders, the other directors and officers of VPCC and Legacy Dave; |
• | “Founder Holders” are to the Sponsor and the Prior Independent Directors, in each case solely in their capacity as holders of VPCC Class B Common Stock as of immediately prior to the Closing and the Founder Holder Class B Conversion; |
• | “Founder Shares” are, if prior to the Effective Time, to the 6,344,150 shares of VPCC Class B Common Stock initially purchased by the Sponsor in a private placement prior to the IPO, and if after the Effective Time, to the shares of VPCC Class A Common Stock after giving effect to the Founder Holder Class B Conversion, originally issued in a private placement to the Sponsor in connection with the IPO; |
• | “Founder Holder Class B Conversion” are to the conversion in connection with the Closing of the outstanding shares of VPCC Class B Common Stock on a one-for-one |
• | “Initial Public Offering” or “IPO” are to VPCC’s initial public offering of Units, the base offering of which closed on March 4, 2021; |
• | “initial shareholders” are to the holders of the Founder Shares, which includes the Sponsor and the Independent Directors; |
• | “Investor Rights Agreement” are to that certain Investor Rights Agreement dated January 5, 2022, by and among Dave, the Founder Holders and certain holders of Legacy Dave Capital Stock in respect of the shares of Common Stock held by such holders following the Closing; |
• | “IRS” are to the Internal Revenue Service; |
• | “Legacy Dave” are to Dave Inc., a Delaware corporation, prior to the Mergers; |
• | “Legacy Dave Capital Stock” are to shares of Legacy Dave Common Stock and Legacy Dave Restricted Stock; |
• | “Legacy Dave Class A Common Stock” are to the shares of Legacy Dave’s Class A common stock, par value $0.00001 per share; |
• | “Legacy Dave Class V Common Stock” are to the shares of Legacy Dave’s Class V common stock, par value $0.00001 per share; |
• | “Legacy Dave Common Stock” are to shares of Legacy Dave Class A Common Stock and Legacy Dave Class V Common Stock; |
• | “Legacy Dave Preferred Stock” are to the Legacy Dave Series A Preferred Stock, Legacy Dave Series B-1 Preferred Stock and Legacy Dave Series B-2 Preferred Stock; |
• | “Legacy Dave Series A Preferred Stock” are to the shares of Legacy Dave Series A convertible preferred stock, par value per share $0.000001; |
• | “Legacy Dave Series B-1 Preferred Stock” are to the shares of Legacy Dave Series B-1 convertible preferred stock, par value per share $0.000001; |
• | “Legacy Dave Series B-2 Preferred Stock” are to the shares of Legacy Dave Series B-2 convertible preferred stock, par value per share $0.000001; |
• | “Legacy Dave Restricted Stock” are to the restricted shares of Legacy Dave granted pursuant to the Legacy Dave Stock Plan; |
• | “Legacy Dave Stock Plan” are to the 2017 Stock Plan of Legacy Dave; |
• | “Legacy Dave Warrants” are to the warrants to purchase Legacy Dave Capital Stock outstanding immediately prior to the Effective Time; |
• | “management” or our “management team” are to our officers and directors; |
• | “Merger Agreement” are to that certain Agreement and Plan of Merger, dated June 7, 2021, by and among Legacy Dave, VPCC, First Merger Sub and Second Merger Sub; |
• | “Mergers” are to the First Merger and Second Merger; |
• | “Nasdaq” are to The Nasdaq Stock Market LLC; |
• | “Organizational Documents” are to the Dave Charter and Dave Bylaws; |
• | “PIPE Investment” are to the transactions contemplated by the Subscription Agreements, entered into in connection with the execution of the Merger Agreement; |
• | “PIPE Investors” are to the qualified institutional buyers and accredited investors that purchased shares of Dave Class A Common Stock in the PIPE Investment; |
• | “Prior Independent Directors” are to Janet Kloppenburg, Peter Offenhauser and Kurt Summers; |
• | “Private Warrants” are to warrants to purchase one share of VPCC Class A Common Stock originally issued to the Sponsor in a private placement simultaneously with the closing of the IPO; |
• | “Proxy Statement/Prospectus” means the final prospectus and definitive proxy statement, dated December 9, 2021 and filed with the SEC on December 13, 2021, together with the supplements subsequently filed with the SEC; |
• | “Public Shares” are to shares of VPCC Class A Common Stock sold as part of the Units in the IPO (whether purchased in the IPO or thereafter in the open market); |
• | “Public Warrants” are to the warrants originally sold as part of the Units in the IPO (whether purchased in the IPO or thereafter in the open market); |
• | “SEC” are to the U.S. Securities and Exchange Commission; |
• | “Second Merger” are to the merger of Legacy Dave (as the surviving entity of the First Merger) with and into Second Merger Sub, with Second Merger Sub surviving the merger as a wholly owned subsidiary of VPCC; |
• | “Second Merger Sub” are to Bear Merger Company II LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of VPCC, which changed its name to Dave Operating LLC subsequent to the Second Merger; |
• | “Securities Act” are to the Securities Act of 1933, as amended; |
• | “Selling Securityholders” are to the selling securityholders named in this prospectus; |
• | “Subscription Agreements” are to those certain Subscription Agreements, dated as of June 7, 2021, by and among VPCC and the PIPE Investors, pursuant to which the PIPE investors agreed to purchase an aggregate of 21,000,000 shares of Dave Class A Common Stock in a private placement for an aggregate purchase price of $210,000,000; |
• | “VPCC” are to VPC Impact Acquisition Holdings III, Inc., a Delaware corporation; |
• | “VPCC Class A Common Stock” are to VPCC’s Class A common stock, par value $0.0001 per share, which following the Closing, is Dave Class A Common Stock; |
• | “VPCC Class B Common Stock” are to VPCC’s Class B common stock, par value $0.0001 per share; |
• | “Transactions” are to the Mergers together with the other transactions contemplated by the Merger Agreement; |
• | “Trust Account” are to the trust account established at the consummation of VPCC’s initial public offering that held the proceeds of the initial public offering and was maintained by Continental Stock Transfer & Trust Company, acting as trustee; |
• | “Units” are to VPCC’s units sold in the IPO, each of which consisted of one Public Share and one-fourth of one Public Warrant; |
• | “U.S. GAAP” are to the generally accepted accounting principles in the United States; |
• | “Legacy Dave Options” are to options to purchase shares of Legacy Dave Capital Stock pursuant to the Legacy Dave Stock Plan; |
• | “Warrant Agreement” are to the Warrant Agreement, dated March 4, 2021, between VPCC and Continental Stock Transfer & Trust Company, as warrant agent; |
• | “Written Consent Party” are to the Legacy Dave Stockholders (including Jason Wilk, the Chief Executive Officer and Co-Founder of Dave) who collectively held holding sufficient number, type and classes of Dave equity interests to obtain the Requisite Legacy Dave Stockholder Approval; and |
• | “Requisite Legacy Dave Stockholder Approval” are to the Legacy Dave Stockholders collectively holding sufficient number, type and classes of Legacy Dave Capital Stock, adopting and approving the Merger Agreement and the transactions contemplated thereby and constituting the requisite approval under the DGCL and Dave’s governance documents with respect to the Merger Agreement and the transactions contemplated thereby. |
• | the ability to maintain the listing of Dave Class A Common Stock on Nasdaq; |
• | the risk that the Business Combination disrupts current plans and operations of Legacy Dave; |
• | the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition and the ability of Dave to manage its growth following the Business Combination; |
• | the ability of Dave to protect intellectual property and trade secrets; |
• | changes in applicable laws or regulations and extensive and evolving government regulations that impact operations and business; |
• | the ability to attract or maintain a qualified workforce; |
• | level of product service failures that could lead Dave members (“Members”) to use competitors’ services; |
• | investigations, claims, disputes, enforcement actions, litigation and/or other regulatory or legal proceedings; |
• | the effects of the COVID-19 pandemic on Dave’s business; |
• | the possibility that Dave may be adversely affected by other economic, business, and/or competitive factors; and |
• | other risks and uncertainties described under the section titled “Risk Factors” of this prospectus. |
Issuer |
Dave Inc. (f/k/a VPC Impact Acquisition Holdings III, Inc). |
Shares of Dave Class A Common Stock offered by us |
59,895,003 shares of Dave Class A Common Stock, consisting of |
• | 48,450,639 shares of Dave Class A Common Stock that are issuable upon conversion of 48,450,639 outstanding shares of Dave Class V Common Stock; |
• | 5,100,214 shares of Dave Class A Common Stock that are issuable upon the exercise of 5,100,214 Private Warrants; and |
• | 6,344,150 shares of Dave Class A Common Stock that are issuable upon the exercise of 6,344,150 Public Warrants. |
Shares of Dave Class A Common Stock outstanding prior to exercise of all Dave Warrants and conversion of all Dave Class V Common Stock |
323,549,861 shares of Dave Class A Common Stock (as of January 5, 2022). |
Shares of Dave Class A Common Stock outstanding assuming exercise of all Dave Warrants and conversion of all Dave Class V Common Stock |
383,444,864 shares of Dave Class A Common Stock (as of January 5, 2022). |
Exercise Price of Private Warrants and Public Warrants |
$11.50 per share, subject to adjustments as described herein. |
Use of proceeds |
We will receive up to an aggregate of approximately $131.61 million from the exercise of the Dave Warrants, assuming the exercise in full of all of the Dave Warrants for cash. We will receive up to an aggregate of approximately $0.21 million from the exercise of Option Shares, assuming the exercise in full of all of the Option Shares for cash. We expect to use the net proceeds from the exercise of the Dave Warrants and Option Shares, if any, for general corporate purposes. See “ Use of Procee |
Securities offered by the Selling Securityholders |
331,404,740 shares of Dave Class A Common Stock, consisting of: |
• | 21,000,000 shares of Dave Class A Common Stock issued in the PIPE Financing; |
• | 5,392,528 Founder Shares; |
• | 244,949,074 shares of Dave Class A Common Stock issued upon consummation of our business combination pursuant to the Merger Agreement and held by certain of our directors and officers and other holders of registration rights; |
• | 48,450,639 shares of Dave Class A Common Stock that are issuable upon conversion of 48,450,639 outstanding shares of Dave Class V Common Stock held by Jason Wilk, our Chief Executive Officer; |
• | 6,344,150 shares of Dave Class A Common Stock that are issuable upon the exercise of 6,344,150 Public Warrants; |
• | 168,135 shares of Dave Class A Common Stock underlying Legacy Dave Options held by certain former employees of Legacy Dave; and |
• | 5,100,214 shares of Dave Class A Common Stock that are issuable upon the exercise of 5,100,214 Private Warrants. |
Dave Warrants offered by the Selling Securityholders |
5,100,214 Private Warrants. |
Terms of the offering |
The Selling Securityholders will determine when and how they will dispose of the shares of Dave Class A Common Stock and Private Warrants registered under this prospectus for resale. |
Use of proceeds |
We will not receive any proceeds from the sale of shares of Dave Class A Common Stock or Private Warrants (assuming the cashless exercise provision is used) by the Selling Securityholders. |
Lock-Up Restrictions |
Certain of our stockholders are subject to certain restrictions on transfer until the termination of applicable lock-up periods. See “Certain Relationships and Related Transactions — Lock-Up Arrangements |
Risk Factors |
See “ Risk Factors |
Nasdaq Stock Market Symbols |
Our Dave Class A Common Stock and Public Warrants are listed on the Nasdaq Global Market under the symbols “DAVE” and “DAVEW,” respectively. |
• | The industries in which we compete are highly competitive, which could adversely affect our results of operations. |
• | If we are unable to keep pace with the rapid technological developments in our industry and the larger financial services industry necessary to continue providing our Members with new and innovative products and services, the use of our platform and other products and services could decline. In addition, if the prices we charge for our products and services are unacceptable to our Members, our operating results will be harmed. |
• | Our non-recourse cash advances expose us to credit risk of our Members and if our underwriting criteria for making advances is not sufficient to mitigate against this risk, our financial condition and operating results could be adversely affected if a substantial number of our Members fail to repay the cash advance they receive. |
• | We may not be able to scale our business quickly enough to meet our Members’ growing needs, and if we are not able to grow efficiently, our operating results could be harmed. |
• | If we are unable to acquire new Members and retain our current members or sell additional functionality and services to them, our revenue growth will be adversely affected. |
• | We have historically incurred losses in the operation of our business. We may never achieve or sustain profitability. |
• | We operate in an uncertain regulatory environment and may from time to time be subject to governmental investigations or other inquiries by state, federal and local governmental authorities. |
• | The financial services industry continues to be targeted by new laws or regulations in many jurisdictions, including the U.S. states in which we operate, that could restrict the products and services we offer, impose additional compliance costs on us, render our current operations unprofitable or even prohibit our current operations. |
• | Our business is subject to extensive regulation and oversight in a variety of areas, including registration and licensing requirements under federal, state and local laws and regulations. |
• | Stringent and changing laws and regulations relating to privacy and data protection could result in claims, harm our results of operations, financial condition, and future prospects, or otherwise harm our business. |
• | Legacy Dave identified material weaknesses in its internal control over financial reporting, which for the years ended December 31, 2020 and 2019 resulted in a restatement of its financial statements, and if Dave is unable to remediate these material weaknesses, or if it identifies additional material weaknesses in the future or otherwise fails to maintain effective internal control over financial reporting, it may not be able to accurately or timely report its financial condition or results of operations, which may adversely affect Dave’s business and share price. |
• | Dave’s forecasted operating results and projections rely in large part upon assumptions, analyses and internal estimates developed by Dave’s management. If these assumptions, analyses or estimates prove |
to be incorrect or inaccurate, Dave’s actual operating results may differ materially and adversely from those forecasted or projected. |
• | Fraudulent and other illegal activity involving our products and services could lead to reputational damage to us, reduce the use of our platform and services and may adversely affect our financial position and results of operations. |
• | In the normal course of business, we collect, process, use and retain sensitive and confidential information regarding our Members and prospective Members, including data provided by and related to Members and their transactions, as well as other data of the counterparties to their payments. A data security breach could expose us to liability and protracted and costly litigation, and could adversely affect our reputation and operating revenues. |
• | Dave’s management has limited experience in operating a public company. |
• | We transfer funds to our Members daily, which in the aggregate comprise substantial sums, and are subject to the risk of errors, which could result in financial losses, damage to our reputation, or loss of trust in our brand, which would harm our business and financial results. |
• | Dave, Inc. has guaranteed up to $50,000,000 of one of its subsidiary’s obligations under a credit facility, and currently that limited guaranty is secured by a first-priority lien against substantially all of Dave, Inc.’s assets. The credit facility contains financial covenants and other restrictions on our actions, which could limit our operational flexibility and otherwise adversely affect our financial condition. |
• | If our present or any future key banking relationships are terminated and we are not able to secure or successfully migrate client portfolios to a new bank partner or partners, our business would be adversely affected. |
• | We depend upon several third-party service providers for processing our transactions and provide other important services for our business. If any of our agreements with our processing providers are terminated or if we experience any interruption or delay in the services provided by our third-party service providers, delivery of our products and services could be impaired or suspended and our business could suffer. |
• | Our recent rapid growth, including growth in our volume of payments, may not be indicative of future growth, and if we continue to grow rapidly, we may not be able to manage our growth effectively. Our rapid growth also makes it difficult to evaluate our future prospects and may increase the risk that we will not be successful. |
• | build a well-recognized, trusted and respected brand; |
• | establish and expand our Member base; |
• | successfully market our products and services; |
• | properly price our services and successfully anticipate the usage of such services by our Members; |
• | improve and maintain our operational efficiency; |
• | maintain a reliable, secure, high-performance and scalable technology infrastructure; |
• | predict our future revenues and appropriately budget our expenses; |
• | attract, retain and motivate talented employees; |
• | anticipate trends that may emerge and affect our business; |
• | anticipate and adapt to changing market conditions, including technological developments and changes in competitive landscape; and |
• | navigate an evolving and complex regulatory environment. |
• | price our products and services effectively to attract new Members; |
• | Create new products and expand the functionality and scope of the products we offer on our platform; |
• | maintain the rates at which Members subscribe to and continue to use our platform; |
• | provide our members with high-quality support that meets their needs; |
• | introduce our products to new markets; |
• | successfully identify and acquire or invest in businesses, products or technologies that we believe could complement or expand our platform; |
• | increase awareness of our brand and successfully compete with other companies; and |
• | manage the risks related to the effects of the COVID-19 pandemic on our business and operations. |
• | product development, including investments in our product development team and the development of new products and new functionality for our platform; |
• | sales, marketing and customer success; |
• | technology infrastructure, including systems architecture, scalability, availability, performance and security; |
• | acquisitions and/or strategic investments; |
• | regulatory compliance and risk management; and |
• | general administration, including increased legal and accounting expenses associated with being a public company. |
• | market our products and services; |
• | hire additional marketing, client support, engineering, product development and administrative personnel; and |
• | expand our client support and service operations; and |
• | implement new and upgraded operational and financial systems, procedures and controls. |
• | the election by our Members of expedited processing of our non-recourse cash advance product; |
• | the timing and volume of tips our Members send to us; |
• | the timing and volume of advance repayments; |
• | the timing and volume of subscriptions and use of our products and services; |
• | the timing and success of new product or service introductions by us or our competitors; |
• | fluctuations in Member retention rates; |
• | changes in the mix of products and services that we provide to our Members; |
• | the timing of commencement of new product development and initiatives, the timing of costs of existing product roll-outs and the length of time we must invest in those new products before they generate material operating revenues; |
• | our ability to effectively sell our products through direct-to-consumer initiatives; |
• | changes in our or our competitors’ pricing policies or sales terms; |
• | costs associated with significant changes in our risk policies and controls; |
• | the amount and timing of costs related to fraud losses; |
• | the amount and timing of commencement and termination of major advertising campaigns, including partnerships and sponsorships; |
• | disruptions in the performance of our products and services, and the associated financial impact thereof; |
• | the amount and timing of costs of any major litigation to which we are a party; |
• | the amount and timing of costs related to the acquisition of complementary businesses; |
• | the amount and timing of capital expenditures and operating costs related to the maintenance and expansion of our business; |
• | changes in our executive leadership team; |
• | our ability to control costs, including third-party service provider costs and sales and marketing expenses in an increasingly competitive market; and |
• | changes in the political or regulatory environment affecting the banking or financial technology service industries. |
• | loss of Members; |
• | lost or delayed market acceptance and sales of our products and services; |
• | legal claims against us; |
• | regulatory enforcement action; or |
• | diversion of our resources, including through increased service expenses or financial concessions, and increased insurance costs. |
• | Dave did not design and maintain certain formal accounting policies, procedures, and internal controls to achieve complete, accurate and timely financial accounting, reporting and disclosures, including internal controls over the period-end financial reporting process addressing financial statement and footnote presentation and disclosures, account reconciliations, and journal entries. Additionally, the lack of a sufficient number of accounting and finance professionals resulted in an inability to consistently establish appropriate authorities and responsibilities in pursuit of Dave’s financial reporting objectives, as demonstrated by, amongst other things, insufficient segregation of duties within the finance and accounting functions. |
• | Dave did not design and maintain effective controls over information technology (“IT”) general controls for information systems that are relevant to the preparation of its financial statements, specifically, with respect to: (i) program change management controls to ensure that IT program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs, and data to appropriate company personnel: and (iii) computer operations controls to ensure that critical batch jobs are monitored and data backups are authorized and monitored. |
• | actual or anticipated fluctuations in operating results; |
• | failure to meet or exceed financial estimates and projections of the investment community or that Dave provides to the public; |
• | issuance of new or updated research or reports by securities analysts or changed recommendations for the industry in general; |
• | announcements of significant acquisitions, strategic partnerships, joint ventures, collaborations or capital commitments; |
• | operating and share price performance of other companies in the industry or related markets; |
• | the timing and magnitude of investments in the growth of the business; |
• | actual or anticipated changes in laws and regulations; |
• | additions or departures of key management or other personnel; |
• | increased labor costs; |
• | disputes or other developments related to intellectual property or other proprietary rights, including litigation; |
• | the ability to market new and enhanced solutions on a timely basis; |
• | sales of substantial amounts of the Dave Class A Common Stock by Dave’s directors, executive officers or significant stockholders or the perception that such sales could occur; |
• | changes in capital structure, including future issuances of securities or the incurrence of debt; and |
• | general economic, political and market conditions. |
• | may significantly dilute the equity interests of our investors; |
• | could cause a change in control if a substantial number of shares of Dave Class A Common Stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and |
• | may adversely affect prevailing market prices for the Dave Class A Common Stock and/or the Public Warrants. |
• | a limited availability of market quotations for our securities; |
• | reduced liquidity for our securities; |
• | a determination that the Dave Class A Common Stock is a “penny stock” which will require brokers trading in the Dave Class A Common Stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; |
• | a limited amount of news and analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | actual or anticipated fluctuations in our quarterly financial results or the quarterly financial results of companies perceived to be similar to Dave; |
• | changes in the market’s expectations about Dave’s operating results; |
• | success of competitors; |
• | Dave’s operating results failing to meet the expectation of securities analysts or investors in a particular period; |
• | changes in financial estimates and recommendations by securities analysts concerning Dave or the market in general; |
• | operating and stock price performance of other companies that investors deem comparable to Dave; |
• | Dave’s ability to market new and enhanced products and technologies on a timely basis; |
• | changes in laws and regulations affecting Dave’s business; |
• | Dave’s ability to meet compliance requirements; |
• | commencement of, or involvement in, litigation involving Dave; |
• | changes in Dave’s capital structure, such as future issuances of securities or the incurrence of additional debt; |
• | the volume of Dave Class A Common Stock available for public sale; |
• | any major change in the Board or management; |
• | sales of substantial amounts of Dave Class A Common Stock by Dave’s directors, executive officers or significant stockholders or the perception that such sales could occur; and |
• | general economic and political conditions such as recessions, interest rates, fuel prices, international currency fluctuations and acts of war or terrorism. |
(unaudited) For the Nine Months Ended September 30, |
For the Year Ended December 31, |
|||||||||||||||
2021 |
2020 |
2020 |
2019 |
|||||||||||||
(in thousands, except per share data) |
(in thousands, except per share data) |
|||||||||||||||
Consolidated Statement of Operations Data: |
||||||||||||||||
Operating revenues: |
||||||||||||||||
Service based revenue, net |
$ | 104,142 | $ | 85,614 | $ | 120,595 | $ | 76,194 | ||||||||
Transaction based revenue, net |
7,711 | 730 | 1,201 | 33 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating revenues, net |
111,853 |
86,344 |
121,796 |
76,227 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses: |
||||||||||||||||
Provision for unrecoverable advances |
21,693 | 14,311 | 25,539 | 19,688 | ||||||||||||
Processing and servicing fees |
16,920 | 15,696 | 21,646 | 15,216 | ||||||||||||
Advertising and marketing |
38,844 | 22,642 | 38,019 | 22,934 | ||||||||||||
Compensation and benefits |
34,685 | 14,898 | 22,210 | 9,242 | ||||||||||||
Other operating expenses |
31,987 | 10,032 | 15,763 | 7,370 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
144,129 |
77,579 |
123,177 |
74,450 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other (income) expense: |
||||||||||||||||
Interest income |
(610 | ) | (339 | ) | (409 | ) | (429 | ) | ||||||||
Interest expense |
1,494 | 3 | 17 | 852 | ||||||||||||
Gain on conversion of 2018 convertible notes |
— | — | — | (841 | ) | |||||||||||
Derivative liability |
— | — | — | 536 | ||||||||||||
Legal settlement and litigation expenses |
952 | 948 | 4,467 | 327 | ||||||||||||
Other strategic financing and transactional expenses |
253 | 1,305 | 1,356 | — | ||||||||||||
Derivative asset on loans to stockholders |
(33,043 | ) | — | — | — | |||||||||||
Changes in fair value of warrant liability |
3,480 | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total other (income) expenses, net |
(27,474 |
) |
1,917 |
5,431 |
445 |
|||||||||||
|
|
|
|
|
|
|
|
(unaudited) For the Nine Months Ended September 30, |
For the Year Ended December 31, |
|||||||||||||||
2021 |
2020 |
2020 |
2019 |
|||||||||||||
(in thousands, except per share data) |
(in thousands, except per share data) |
|||||||||||||||
Net (loss) income before income tax (benefit) expense |
(4,802 |
) |
6,848 |
(6,812 |
) |
1,332 |
||||||||||
Income tax (benefit) expense |
(1 | ) | (20,805 | ) | 145 | 545 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net (loss) income |
$ |
(4,801 |
) |
$ |
27,653 |
$ |
(6,957 |
) |
$ |
787 |
||||||
|
|
|
|
|
|
|
|
|||||||||
Net (loss) income per share: |
||||||||||||||||
Basic |
$ | (0.05 | ) | $ | 0.08 | $ | (0.08 | ) | $ | 0.00 | ||||||
Diluted |
$ | (0.05 | ) | $ | 0.08 | $ | (0.08 | ) | $ | 0.00 | ||||||
Weighted-average shares used to compute net (loss) income per share |
||||||||||||||||
Basic |
100,176,295 | 88,943,115 | 90,986,048 | 76,918,167 | ||||||||||||
Diluted |
100,176,295 | 99,364,554 | 90,986,048 | 247,773,818 |
• | Existing Legacy Dave Stockholders collectively own a majority of the outstanding shares of the Company immediately following the Closing (92.1% after redemptions of the public stockholders of VPCC) and hold a majority of the voting power immediately following the Closing (96.4% after redemptions of the public stockholders of VPCC); |
• | by virtue of such voting interest upon the Closing, existing Legacy Dave Stockholders have the ability to control decisions regarding the election and removal of directors and officers of the Company following the Closing; |
• | Dave’s senior management will be the senior management of the Company. |
• | Sixty percent (60%) of the Founder Holder Earnout Shares (951,622 Founder Holder Earnout Shares) shall immediately become fully vested and no longer subject to forfeiture upon the occurrence of Triggering Event I, which is defined as the first date on which the Common Share Price is equal to or greater than twelve dollars and fifty cents ($12.50) after the Closing Date, but within the Earnout Period (as defined in the Merger Agreement); provided, that |
(i) | in the event of a change of control pursuant to which Dave Stockholders receive, or have the right to receive, cash, securities or other property attributing a value of at least twelve dollars and fifty cents ($12.50) to each share of Class A Common Stock (as agreed in good faith by the Sponsor and the Board), then Triggering Event I shall be deemed to have occurred and; |
(ii) | in the event that, and as often as, the number of outstanding shares of Class A Common Stock is changed by reason of any dividend, subdivision, reclassification, recapitalization, split, combination, exchange or any similar event, then the applicable Common Share Price (as defined in the Merger Agreement) threshold (i.e., twelve dollars and fifty cents ($12.50)) will, for all purposes of the Merger Agreement (and the Founder Holder Agreement), in each case be equitably adjusted to reflect such change; and |
• | The remaining Founder Holder Earnout Shares (634,415 Founder Holder Earnout Shares) shall immediately become fully vested and no longer subject to forfeiture upon the occurrence of Triggering |
Event II, which is defined as the first date on which the Common Share Price is equal to or greater than fifteen dollars ($15.00) after the Closing Date, but within the Earnout Period; provided, that |
(i) | in the event of a change of control pursuant to which Dave Stockholders receive, or have the right to receive, cash, securities or other property attributing a value of at least fifteen dollars ($15.00) to each share of Class A Common Stock (as agreed in good faith by Sponsor and the Board), then Triggering Event II shall be deemed to have occurred and; |
(ii) | in the event that, and as often as, the number of outstanding shares of Class A Common Stock is changed by reason of any dividend, subdivision, reclassification, recapitalization, split, combination, exchange or any similar event, then the applicable Common Share Price threshold (i.e., fifteen dollars ($15.00)) will, for all purposes of the Merger Agreement (and the Founder Holder Agreement), in each case be equitably adjusted to reflect such change. |
• | the First Merger; |
• | immediately following the consummation of the First Merger, the Second Merger; |
• | the consummation of the Business Combination and reclassification of cash held in the Trust Account to cash and cash equivalents, net of redemptions (see below); |
• | the consummation of the PIPE Investment; |
• | the conversion of certain Legacy Dave liabilities to equity; |
• | the conversion of the Series A, Series B-1 and Series B-2 Convertible Preferred Shares (“Legacy Dave Preferred Stock”) to permanent equity; |
• | the exercise and net settlement of the Legacy Dave warrants issued in connection with the senior secured debt facility; |
• | the accounting for transaction costs incurred by both VPCC and Legacy Dave; |
• | the exercise of the Legacy Dave call options and derecognition of the related loans, related accrued interest receivable and derivative asset to stockholders; |
• | the accounting for Mr. Wilk’s stock options which include vesting terms satisfied by the Business Combination; and |
• | the discharge of Legacy Dave’s obligation to pay the Promissory Note in exchange for shares of the Company. |
Class A Shares |
Class V Shares |
% |
||||||||||
Stockholders |
||||||||||||
Former Dave stockholders and preferred shareholders |
294,198,502 | 48,450,639 | 92.1 | % | ||||||||
VPCC sponsor shares (1) |
3,806,491 | — | 1.0 | % | ||||||||
Founder Holder Earnout Shares (2) |
1,586,037 | — | 0.4 | % | ||||||||
VPCC public stockholders |
2,958,831 | — | 0.8 | % | ||||||||
PIPE Investment |
21,000,000 | — | 5.7 | % | ||||||||
|
|
|
|
|
|
|||||||
Total shares of Dave common stock outstanding at closing of the Transaction |
323,549,861 | 48,450,639 | 100.0 | % |
(1) | Gives effect to the Founder Holders’ forfeiture of an aggregate of 951,622 shares of VPCC’s Class B common stock as the net redemption percentage exceeded 35% per the Business Combination Agreement. |
(2) | Founder Holder Earnout Shares subject to market vesting conditions: (i) 951,622 Founder Holder Earnout Shares are vested upon Triggering Event I and (ii) 634,415 Founder Holder Earnout Shares are vested upon Triggering Event II. |
As of September 30, 2021 |
As of September 30, 2021 |
|||||||||||||||||||
Dave, Inc. (Historical) |
VPC Impact Acquisition Holdings III, Inc. (Historical) |
Transaction Accounting Adjustments |
Pro Forma Combined |
|||||||||||||||||
Assets |
||||||||||||||||||||
Current assets: |
||||||||||||||||||||
Cash and cash equivalents |
$ | 21,307 | $ | 120 | 253,782 | 3A |
$ | 216,973 | ||||||||||||
195,000 | 3D |
|||||||||||||||||||
(29,041 | ) | 3H |
||||||||||||||||||
(224,195 | ) | 3B |
||||||||||||||||||
Marketable securities |
13,755 | — | 13,755 | |||||||||||||||||
Member advances, net of allowance for unrecoverable advances |
44,868 | — | 44,868 | |||||||||||||||||
Prepaid income taxes |
2,701 | — | 2,701 | |||||||||||||||||
Deferred issuance costs |
3,469 | (3,469 | ) | 3H |
— | |||||||||||||||
Prepaid expenses and other current assets |
3,478 | — | 3,478 | |||||||||||||||||
Prepaid expenses |
— | 918 | 918 | |||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total current assets |
89,578 |
1,038 |
192,077 |
282,693 |
||||||||||||||||
Property and equipment, net |
636 | — | 636 | |||||||||||||||||
Lease right-of-use |
3,169 | — | 3,169 | |||||||||||||||||
Intangible assets, net |
6,504 | — | 6,504 | |||||||||||||||||
Derivative asset on loans to stockholders |
33,505 | — | (33,505 | ) | 3K |
— | ||||||||||||||
Debt facility commitment fee, long-term |
145 | 145 | ||||||||||||||||||
Restricted cash, net of current portion |
319 | — | 319 | |||||||||||||||||
Investments held in Trust Account |
— | 253,782 | (253,782 | ) | 3A |
— | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total assets |
$ |
133,856 |
$ |
254,820 |
(95,210 |
) |
$ |
293,466 |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Liabilities, convertible preferred stock, and stockholders’ deficit |
||||||||||||||||||||
Current liabilities: |
||||||||||||||||||||
Accounts payable |
$ | 14,577 | $ | — | $ | 14,577 | ||||||||||||||
Accrued expenses |
9,836 | 2,269 | 12,105 | |||||||||||||||||
Lease liabilities, short-term |
1,898 | 1,898 | ||||||||||||||||||
Legal settlement accrual |
3,201 | 3,201 | ||||||||||||||||||
Note payable |
14,608 | (14,608 | ) | 3I |
— | |||||||||||||||
Other current liabilities |
777 | — | 777 | |||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total current liabilities |
44,897 |
2,269 |
(14,608 |
) |
32,558 |
|||||||||||||||
Lease liabilities, long-term |
1,484 | — | 1,484 | |||||||||||||||||
Long-term debt facility |
30,000 | 30,000 | ||||||||||||||||||
Convertible debt, long-term |
695 | — | (695 | ) | 3E |
— | ||||||||||||||
Interest payable, convertible notes |
22 | — | (22 | ) | 3E |
— | ||||||||||||||
Warrant liability |
3,586 | 21,811 | (3,586 | ) | 3L |
21,811 | ||||||||||||||
Other non-current liabilities |
545 | — | 545 | |||||||||||||||||
Deferred underwriting fee payable |
— | 8,882 | 8,882 | |||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total liabilities |
81,229 |
32,962 |
(18,911 |
) |
95,280 |
|||||||||||||||
|
|
|
|
|
|
|
|
As of September 30, 2021 |
As of September 30, 2021 |
|||||||||||||||||||
Dave, Inc. (Historical) |
VPC Impact Acquisition Holdings III, Inc. (Historical) |
Transaction Accounting Adjustments |
Pro Forma Combined |
|||||||||||||||||
Commitments and contingencies (Note 11) |
||||||||||||||||||||
Convertible preferred stock |
||||||||||||||||||||
Series A convertible preferred stock, par value per share $0.000001 |
9,881 | — | (9,881 | ) | 3F |
$ |
— |
|||||||||||||
Series B-1 convertible preferred stock, par value per share $0.000001 |
49,675 | — | (49,675 | ) | 3F |
— | ||||||||||||||
Series B-2 convertible preferred stock, par value per share $0.000001 |
12,617 | — | (12,617 | ) | 3F |
— | ||||||||||||||
Class A common stock subject to possible redemption |
— | 253,766 | (253,766 | ) | 3C |
— | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total Convertible preferred stock |
72,173 |
253,766 |
(325,939 |
) |
— |
|||||||||||||||
Stockholders’ deficit: |
||||||||||||||||||||
Common stock, par value per share $0.000001 |
0.1 | — | — | 3E |
0.1 | |||||||||||||||
— | 3F |
|||||||||||||||||||
— | 3G |
|||||||||||||||||||
— | 3K |
|||||||||||||||||||
Preferred stock, $0.0001 par value |
— | — | — | |||||||||||||||||
Class A common stock, $0.0001 par value |
— | — | 2 | 3C |
2 | |||||||||||||||
(2 | ) | 3B |
(2 | ) | ||||||||||||||||
Class B common stock, $0.0001 par value |
— | 1 | (1 | ) | 3G |
— | ||||||||||||||
Class V common stock, $0.0001 par value |
1 | 3G |
1 | |||||||||||||||||
Treasury stock |
(5 | ) | — | (5 | ) | |||||||||||||||
Additional paid-in capital |
13,285 | — | 253,764 | 3C |
228,672 | |||||||||||||||
195,000 | 3D |
|||||||||||||||||||
717 | 3E |
|||||||||||||||||||
72,173 | 3F |
|||||||||||||||||||
(31,909 | ) | 3G |
||||||||||||||||||
(21,678 | ) | 3H |
||||||||||||||||||
1,945 | 3J |
|||||||||||||||||||
(15,121 | ) | 3K |
||||||||||||||||||
(33,505 | ) | 3K |
||||||||||||||||||
3,586 | 3L |
|||||||||||||||||||
14,608 | 3I |
|||||||||||||||||||
(224,193 | ) | 3B |
||||||||||||||||||
Loans to stockholders |
(15,121 | ) | — | 15,121 | 3K |
— | ||||||||||||||
Accumulated deficit |
(17,705 | ) | (31,909 | ) | 31,909 | 3G |
(30,482 | ) | ||||||||||||
(10,832 | ) | 3H |
||||||||||||||||||
(1,945 | ) | 3J |
||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total stockholders’ deficit |
(19,546 | ) | (31,908 | ) | 249,640 | 198,186 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||
Total liabilities, convertible preferred stock, and stockholders’ deficit |
$ |
133,856 |
$ |
254,820 |
(95,210 |
) |
$ |
293,466 |
||||||||||||
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2021 |
Period From January 14, 2021 (Inception) Through September 30, 2021 |
Nine Months Ended September 30, 2021 |
||||||||||||||||
Dave, Inc. (Historical) |
VPC Impact Acquisition Holdings III, Inc. (Historical) |
Transaction Accounting Adjustments |
Pro Forma Combined |
|||||||||||||||
Operating revenues: |
||||||||||||||||||
Service based revenue, net |
$ | 104,142 | $ | — | $ | 104,142 | ||||||||||||
Transaction based revenue, net |
7,711 | — | 7,711 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total operating revenues, net |
111,853 | — | — | 111,853 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Operating expenses: |
||||||||||||||||||
Provision for unrecoverable advances |
21,693 | — | 21,693 | |||||||||||||||
Processing and servicing fees |
16,920 | — | 16,920 | |||||||||||||||
Advertising and marketing |
38,844 | — | 38,844 | |||||||||||||||
Compensation and benefits |
34,685 | — | 1,725 | 3EE |
36,410 | |||||||||||||
Other operating expenses |
31,987 | — | 31,987 | |||||||||||||||
Formation and operational costs |
— | 3,402 | 3,402 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total operating expenses |
144,129 | 3,402 | 1,725 | 149,256 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Other (income) expense: |
||||||||||||||||||
Interest income |
(610 | ) | — | 212 | 3GG |
(4 | ) | |||||||||||
394 | 3II |
|||||||||||||||||
Interest expense |
1,494 | — | (9 | ) | 3BB |
1,485 | ||||||||||||
Legal settlement and litigation expenses |
952 | — | 952 | |||||||||||||||
Other strategic financing and transactional expenses |
253 | — | 253 | |||||||||||||||
Derivative asset on loans to stockholders |
(33,043 | ) | — | 33,043 | 3FF |
— | ||||||||||||
Changes in fair value of warrant liability |
3,480 | 3,820 | (3,480 | ) | 3HH |
3,820 | ||||||||||||
Transaction costs allocated to warrant liabilities |
— | 600 | 600 | |||||||||||||||
Interest earned on marketable securities held in Trust Account |
— | (16 | ) | 16 | 3AA |
— | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total other (income) expenses, net |
(27,474 | ) | 4,404 | 30,176 | 7,106 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net (loss) income before provision for income taxes |
(4,802 | ) | (7,806 | ) | (31,901 | ) | (44,509 | ) | ||||||||||
Income tax benefit |
(1 | ) | — | — | 3DD |
$ | (1 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net (loss) income |
$ | (4,801 | ) | $ | (7,806 | ) | $ | (31,901 | ) | $ | (44,508 | ) | ||||||
Net loss per share of common stock - basic and diluted |
$ | (0.05 | ) | |||||||||||||||
Weighted average shares of common stock outstanding - basic |
100,176,295 | |||||||||||||||||
Weighted average shares of common stock outstanding - diluted |
100,176,295 | |||||||||||||||||
Net loss per share - Class A common stock redeemable shares - basic and diluted |
$ | (0.29 | ) | $ | (0.12 | ) | ||||||||||||
Weighted average shares outstanding - Class A common stock redeemable shares - basic and diluted |
20,481,452 | 4 | 321,964,058 | |||||||||||||||
Net loss per share - Class B - basic and diluted |
$ | (0.29 | ) | |||||||||||||||
Weighted average shares outstanding - Class B - basic and diluted |
6,207,710 | |||||||||||||||||
Net loss per share - Class V - basic and diluted |
$ | (0.12 | ) | |||||||||||||||
Weighted average shares outstanding - Class V - basic and diluted |
4 | 48,450,639 |
Year Ended December 31, 2020 |
Year Ended December 31, 2020 |
|||||||||||||||||
Dave, Inc. (Historical) |
VPC Impact Acquisition Holdings III, Inc. (Historical) (1) |
Transaction Accounting Adjustments |
Pro Forma Combined |
|||||||||||||||
As Restated |
||||||||||||||||||
Operating Revenues: |
||||||||||||||||||
Service based revenue, net |
$ | 120,595 | $ | — | $ | 120,595 | ||||||||||||
Transaction based revenue, net |
1,201 | — | 1,201 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total operating revenue, net |
121,796 | — | — | 121,796 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Operating expenses: |
||||||||||||||||||
Provision for unrecoverable advances |
25,539 | — | 25,539 | |||||||||||||||
Processing and servicing fees |
21,646 | — | 21,646 | |||||||||||||||
Advertising and marketing |
38,019 | — | 38,019 | |||||||||||||||
Compensation and benefits |
22,210 | — | 4,235 | 3EE |
26,445 | |||||||||||||
Other operating expenses |
15,763 | — | 10,832 | 3CC |
26,595 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total operating expenses |
123,177 | — | 15,067 | 138,244 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Other (income) expense: |
||||||||||||||||||
Interest income |
(409 | ) | — | 272 | 3GG |
(137 | ) | |||||||||||
Interest expense |
17 | — | (17 | ) | 3BB |
— | ||||||||||||
Legal settlement and litigation expenses |
4,467 | — | 4,467 | |||||||||||||||
Other strategic financing and transactional expenses |
1,356 | — | 1,356 | |||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total other expense, net |
5,431 | — | 255 | 5,686 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Loss before provision for income taxes |
(6,812 | ) | — | (15,322 | ) | (22,134 | ) | |||||||||||
Provision for income taxes |
145 | — | — | 3DD |
145 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net loss |
$ | (6,957 | ) | $ | — | $ | (15,322 | ) | $ | (22,279 | ) | |||||||
Net loss per share of common stock - basic and diluted |
$ | (0.08 | ) | |||||||||||||||
Weighted average shares of common stock outstanding - basic and diluted |
90,986,048 | |||||||||||||||||
Net loss per share - Class A common stock redeemable shares - basic and diluted |
$ | — | $ | (0.06 | ) | |||||||||||||
redeemable shares - basic and diluted |
— | 4 | 321,964,058 | |||||||||||||||
Net loss per share - Class B - basic and diluted |
$ | — | ||||||||||||||||
Weighted average shares outstanding - Class B - basic and diluted |
— | |||||||||||||||||
Net loss per share - Class V - basic and diluted |
$ | — | $ | (0.06 | ) | |||||||||||||
Weighted average shares outstanding - Class V - basic and diluted |
— | 4 | 48,450,639 |
(1) | As VPCC’s date of inception is January 14, 2021, no statement of operations data exists for the year ended December 31, 2020. |
(A) | Reflects the reclassification of $253.8 million held in the Trust Account to cash and cash equivalents. |
(B) | Reflects the reduction in cash and VPCC’s APIC in the amount of $224.2 million related to the redemptions. |
(C) | Reflects the reclassification of VPCC’s Common Stock subject to possible redemption into permanent equity. |
(D) | Reflects cash proceeds from the concurrent PIPE Investment in the amount of $195.0 million and corresponding offset to APIC, excluding the $15.0 million PIPE prefunding with Alameda Research. The total PIPE Investment including the prefunding is $210.0 million. |
(E) | Reflects the conversion of approximately $0.7 million of Legacy Dave convertible notes and approximately $0.02 million of accrued interest into fully vested shares of Company Common Stock. Using an exchange ratio of 1.354387513, the $0.72 million of Legacy Dave liabilities converted into approximately 225,331 shares of Company Common Stock upon the consummation of the Business Combination. |
(F) | Reflects the conversion of the Legacy Dave Preferred Stock into Company Common Stock in accordance with the Merger Agreement. |
(G) | Reflects the elimination of VPCC’s retained earnings and Legacy Dave’s par value of common shares upon consummation of the Business Combination. |
(H) | Reflects an adjustment of approximately $29.0 million to reduce cash and approximately $3.5 million to reduce deferred offering costs for transaction costs incurred by VPCC and Legacy Dave in relation to the Business Combination and PIPE Investment, including advisory, banking, printing, legal and accounting services. As part of the Business Combination, approximately $10.8 million was expensed and recorded in accumulated deficit, and the remaining approximately $21.7 million was determined to be equity issuance costs and offset to APIC. |
(I) | Reflects the conversion of approximately $14.6 million of Legacy Dave notes payable held at fair value related to the amended PIPE subscription agreement in August 2021 with Alameda Research into fully vested shares of Company Common Stock. |
(J) | Reflects compensation expense of approximately $1.7 million recorded in additional-paid-in-capital (EE) |
(K) | Reflects the exercise of Legacy Dave call options in exchange for the forgiveness of the related loans to stockholders of approximately $14.5 million and related accrued interest receivable of $0.6 million. Dave reclassified the loan and derivative asset of approximately $33.5 million to APIC. See Note (FF) |
(L) | Reflects the net share settlement of 1,664,394 Legacy Dave warrants issued in connection with the senior secured debt facility into 332,876 shares immediately prior to the Business Combination. Using an exchange ratio of 1.354387513, the shares converted into approximately 450,843 Company Common Stock on a post combination basis. The cashless exercise is treated as a reclassification of the warrant liability of $3.6 million to APIC, with no repurchase of common stock. |
(AA) | Elimination of interest income and unrealized gain on the Trust Account. |
(BB) | Elimination of interest expense of $0.009 million for the nine months ended September 30, 2021 and $0.02 million for the year ended December 31, 2020 related to Legacy Dave convertible debt that converted to Company Common Stock upon the closing of the Business Combination. |
(CC) | Reflects the transaction costs of $10.8 million as if incurred on January 1, 2020, the date the Business Combination occurred for the purposes of the unaudited pro forma condensed combined statement of operations. This is a non-recurring item. |
(DD) | The net effect of all adjustments impacting the pro forma statement of operations results in a reduction of the income tax benefit of approximately $6.7 million for the nine months ended September 30, 2021 and |
approximately $3.2 million for the year ended December 31, 2020 based on the application of the blended statutory tax rate of 21%. However, Dave has not reflected the income tax benefit in the pro forma statement of operations, as Dave does not believe that the income tax benefit is realizable and records a full valuation allowance against all deferred tax assets. |
(EE) | Reflects estimated compensation expense related to Mr. Wilk’s stock options. The value of the stock options was estimated using a Monte Carlo simulation. This model requires the input of certain assumptions, including the risk-free interest rate, volatility, dividend yield and expected life. The options were granted in nine tranches each of which contain service, market and performance conditions. Vesting commences on the grant date, however, no compensation charges are recognized until the performance condition is probable upon the completion of the Business Combination. On the date of the Business Combination, there is a cumulative expense for the amount vested between the grant date and the date of the Business Combination. Stock-based compensation expense for the nine months ended September 30, 2021 was approximately $1.7 million and approximately $4.2 million for the year ended December 31, 2020, inclusive of a cumulative expense of approximately $1.9 million. The cumulative expense recognized is a non-recurring item. See NOTE (J) non-recurring item. |
(FF) | Reflects the elimination of historical changes in fair value of the call option of approximately $33.0 million for the nine months ended September 30, 2021 and nil for the year ended December 31, 2020. This is a non-recurring item. |
(GG) | Elimination of interest income from the loans to stockholders related to the call option of approximately $0.2 million for the nine months ended September 30, 2021 and approximately $0.3 million for the year ended December 31, 2020. |
(HH) | Reflects the elimination of historical changes in fair value of the Legacy Dave warrant of approximately $3.5 million for the nine months ended September 30, 2021 and nil for the year ended December 31, 2020 upon exercise of the warrant immediately prior to the closing of the Business Combination. This is a non-recurring item. |
(II) | Reflects the elimination of historical changes in fair value of the Legacy Dave Note Payable of approximately $0.4 million for the nine months ended September 30, 2021 and nil for the year ended December 31, 2020. |
(in thousands, except share data) |
||||||||
Redemptions |
||||||||
Stockholders |
Class A Shares |
Class V Shares |
||||||
Numerator |
||||||||
Net loss (in thousands) |
$ | (38,686 | ) | $ | (5,822 | ) | ||
Denominator (1) |
||||||||
Former Dave stockholders and preferred stockholders |
294,198,502 | 48,450,639 | ||||||
VPCC sponsor shares (2) |
3,806,491 | — | ||||||
VPCC public stockholders |
2,958,831 | — | ||||||
PIPE Investment |
21,000,000 | — | ||||||
|
|
|
|
|||||
Total shares of Dave common stock outstanding at closing of the Transaction |
321,963,824 | 48,450,639 | ||||||
Net loss per share |
||||||||
Basic and diluted |
$ | (0.12 | ) | $ | (0.12 | ) |
(1) | The denominator excludes the effect of the Founder Holder Earnout Shares due to the uncertainty related to the market vesting conditions. |
(2) | Gives effect to the Founder Holders’ forfeiture of an aggregate of 951,622 shares of VPCC’s Class B common stock as the net redemption percentage exceeded 35% per the Merger Agreement. |
(in thousands, except share data) |
||||||||
Stockholders |
Class A Shares |
Class V Shares |
||||||
Numerator |
||||||||
Net loss (in thousands) |
$ | (19,365 | ) | $ | (2,914 | ) | ||
Denominator (1) |
||||||||
Former Dave stockholders and preferred stockholders |
294,198,502 | 48,450,639 | ||||||
VPCC sponsor shares (2) |
3,806,491 | — | ||||||
VPCC public stockholders |
2,958,831 | — | ||||||
PIPE Investment |
21,000,000 | — | ||||||
|
|
|
|
|||||
Total shares of Dave common stock outstanding at closing of the Transaction |
321,963,824 | 48,450,639 | ||||||
Net loss per share |
||||||||
Basic and diluted |
$ | (0.06 | ) | $ | (0.06 | ) |
(1) | The denominator excludes the effect of the Founder Holder Earnout Shares due to the uncertainty related to the market vesting conditions. |
(2) | Gives effect to the Founder Holders’ forfeiture of an aggregate of 951,622 shares of VPCC’s Class B common stock as the net redemption percentage exceeded 35% per the Merger Agreement. |
For the Nine Months Ended September 30, (unaudited) |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2021 |
2020 |
2021/2020 |
2021/2020 |
|||||||||||||
Service based revenue, net |
||||||||||||||||
Processing fees, net |
$ | 57,410 | $ | 47,705 | $ | 9,705 | 20 | % | ||||||||
Tips |
33,067 | 25,042 | 8,025 | 32 | % | |||||||||||
Subscriptions |
13,055 | 12,337 | 718 | 6 | % | |||||||||||
Other |
610 | 530 | 80 | 15 | % | |||||||||||
Transaction based revenue, net |
7,711 | 730 | 6,981 | 956 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
111,853 |
$ |
86,344 |
$ |
25,509 |
30 |
% | ||||||||
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, (unaudited) |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2021 |
2020 |
2021/2020 |
2021/2020 |
|||||||||||||
Provision for unrecoverable advances |
$ | 21,693 | $ | 14,311 | $ | 7,382 | 52 | % | ||||||||
Processing and servicing fees |
16,920 | 15,696 | 1,224 | 8 | % | |||||||||||
Advertising and marketing |
38,844 | 22,642 | 16,202 | 72 | % | |||||||||||
Compensation and benefits |
34,685 | 14,898 | 19,787 | 133 | % | |||||||||||
Other operating expenses |
31,987 | 10,032 | 21,955 | 219 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
144,129 |
$ |
77,579 |
$ |
66,550 |
86 |
% | ||||||||
|
|
|
|
|
|
|
|
• | an increase in payroll and related costs of approximately $8.9 million, primarily due to hiring and increased headcount throughout the business; |
• | an increase in consultants and contractor costs of approximately $5.4 million, primarily due to Dave’s need to supplement recruiting efforts, increase IT security, marketing, and augmenting customer service resources; and |
• | an increase in stock-based compensation of approximately $5.4 million, primarily due to an increase of approximately $2.1 million from new stock option grants related to increased headcount to support the growth of the business and an increase of approximately $3.2 million from certain stock options modifications. |
• | an increase in expenses related to Dave’s Checking Product of approximately $13.3 million, primarily attributable to the growth in Members and the number of transactions processed; |
• | an increase in chargeback related expenses of approximately $4.0 million, primarily due to non-recurring fraudulent activity in relation to Dave’s Checking Product (see “Risk Factors—Risks related to Dave’s Business and Industry—Fraudulent and other illegal activity involving our products and services could lead to reputational damage to us, reduce the use of our platform and services and may adversely affect our financial position and results of operations.”); |
• | an increase in charitable contribution expenses of approximately $1.2 million, primarily due to increased amounts pledged to charitable meal donations related to increased Members’ tips; |
• | an increase in technology and infrastructure expenses of approximately $1.8 million, primarily due to increased spending to support the growth of Dave’s business and development of new products and features |
• | an increase in depreciation and amortization of $0.8 million, primarily due to equipment purchases for increased headcount and amortization of internally developed software; and |
• | an increase in rent expense of $0.5 million, primarily due to additional leased office space. |
For the Nine Months Ended September 30, (unaudited) |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2021 |
2020 |
2021/2020 |
2021/2020 |
|||||||||||||
Interest income |
$ | (610 | ) | $ | (339 | ) | $ | (271 | ) | 80 | % | |||||
Interest expense |
1,494 | 3 | 1,491 | 49700 | % | |||||||||||
Legal settlement and litigation expenses |
952 | 948 | 4 | 0 | % | |||||||||||
Other strategic financing and transactional expenses |
253 | 1,305 | (1,052 | ) | -81 | % | ||||||||||
Changes in fair value of derivative asset on loans to stockholders |
(33,043 | ) | — | (33,043 | ) | 100 | % | |||||||||
Changes in fair value of warrant liability |
3,480 | — | 3,480 | 100 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
(27,474 |
) |
$ |
1,917 |
$ |
(29,391 |
) |
-1533 |
% | ||||||
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, (unaudited) |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2021 |
2020 |
2021/2020 |
2021/2020 |
|||||||||||||
Income tax benefit |
$ | (1 | ) | $ | (20,805 | ) | $ | 20,804 | -100 | % | ||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
(1 |
) |
$ |
(20,805 |
) |
$ |
20,804 |
-100 |
% | ||||||
|
|
|
|
|
|
|
|
For the Years Ended December 31, |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2020 |
2019 |
2020/2019 |
2020/2019 |
|||||||||||||
Service based revenue, net |
||||||||||||||||
Processing fees, net |
$ | 66,969 | $ | 45,093 | $ | 21,876 | 49 | % | ||||||||
Tips |
36,189 | 20,684 | 15,505 | 75 | % | |||||||||||
Subscriptions |
16,678 | 9,185 | 7,493 | 82 | % | |||||||||||
Other |
759 | 1,232 | (473 | ) | -38 | % | ||||||||||
Transaction based revenue, net |
1,201 | 33 | 1,168 | 3539 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
121,796 |
$ |
76,227 |
$ |
45,569 |
60 |
% | ||||||||
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2020 |
2019 |
2020/2019 |
2020/2019 |
|||||||||||||
Provision for unrecoverable advances |
$ | 25,539 | $ | 19,688 | $ | 5,851 | 30 | % | ||||||||
Processing and servicing fees |
21,646 | 15,216 | 6,430 | 42 | % | |||||||||||
Advertising and marketing |
38,019 | 22,934 | 15,085 | 66 | % | |||||||||||
Compensation and benefits |
22,210 | 9,242 | 12,968 | 140 | % | |||||||||||
Other operating expenses |
15,763 | 7,370 | 8,393 | 114 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
123,177 |
$ |
74,450 |
$ |
48,727 |
65 |
% | ||||||||
|
|
|
|
|
|
|
|
• | an increase in payroll and related costs of approximately $10.9 million, primarily due to hiring and increased headcount throughout the business; |
• | an increase in consultants and contractor costs of approximately $1.0 million, primarily due to Dave’s need to supplement recruiting efforts, increase IT security, marketing, and augmenting customer service resources; and |
• | an increase in stock-based compensation of approximately $1.1 million, primarily due to new grants related to increased headcount to support the growth of the business. |
• | an increase in expenses related to Dave’s Checking Product of approximately $2.5 million, primarily attributable to the growth in Members and the number of transactions processed; |
• | an increase in charitable contribution expenses of approximately $2.4 million, primarily due to increased amounts pledged to charitable tree and meal donations related to increased Members’ tips; |
• | an increase in technology and infrastructure expenses of approximately $1.9 million, primarily due to increased spending to support the growth of our business and development of new products and features; |
• | an increase in depreciation and amortization of $0.9 million, primarily due to equipment purchases for increased headcount and amortization of internally developed software; and |
• | an increase in fines and penalties of $0.2 million, primarily attributable to fines and penalties related to sales tax filings in certain states. |
For the Year Ended December 31, |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2020 |
2019 |
2020/2019 |
2020/2019 |
|||||||||||||
Interest income |
$ | (409 | ) | $ | (429 | ) | $ | 20 | -5 | % | ||||||
Interest expense |
17 | 852 | (835 | ) | -98 | % | ||||||||||
Gain on conversion of 2018 convertible notes |
— | (841 | ) | 841 | -100 | % | ||||||||||
Derivative liability |
— | 536 | (536 | ) | -100 | % | ||||||||||
Legal settlement and litigation expenses |
4,467 | 327 | 4,140 | 1266 | % | |||||||||||
Other strategic financing and transactional expenses |
1,356 | — | 1,356 | 100 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
5,431 |
$ |
445 |
$ |
4,986 |
1120 |
% | ||||||||
|
|
|
|
|
|
|
|
For the Year Ended December 31, |
Change |
|||||||||||||||
(in thousands, except for percentages) |
$ |
% |
||||||||||||||
2020 |
2019 |
2020/2019 |
2020/2019 |
|||||||||||||
Provision for income taxes |
$ | 145 | $ | 545 | $ | (400 | ) | -73 | % | |||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
145 |
$ |
545 |
$ |
(400 |
) |
-73 |
% | |||||||
|
|
|
|
|
|
|
|
For the Nine Months Ended September 30, |
||||||||
(in thousands) |
2021 |
2020 |
||||||
Net (loss) income |
$ | (4,801 | ) | $ | 27,653 | |||
Interest expense (income), net |
884 | (336 | ) | |||||
Income tax benefit |
(1 | ) | (20,805 | ) | ||||
Depreciation and amortization |
2,059 | 1,219 | ||||||
Stock-based compensation |
6,342 | 932 | ||||||
Legal settlement and litigation expenses |
952 | 948 | ||||||
Other strategic financing and transactional expenses |
253 | 1,305 | ||||||
Changes in fair value of derivative asset on loans to stockholders |
(33,043 | ) | — | |||||
Changes in fair value of warrant liability |
3,480 | — | ||||||
|
|
|
|
|||||
Adjusted EBITDA |
$ |
(23,875 |
) |
$ |
10,916 |
|||
|
|
|
|
For the Year Ended December 31, |
||||||||
(in thousands) |
2020 |
2019 |
||||||
Net (loss) income |
$ | (6,957 | ) | $ | 787 | |||
Interest (income) expense, net |
(392 | ) | 423 | |||||
Provision for income taxes |
145 | 545 | ||||||
Depreciation and amortization |
1,718 | 805 | ||||||
Stock-based compensation |
1,525 | 446 | ||||||
Legal settlement and litigation expenses |
4,467 | 327 | ||||||
Other strategic financing and transactional expenses |
1,356 | — | ||||||
Gain on conversion of 2018 convertible notes |
— | (841 | ) | |||||
Derivative liability |
— | 536 | ||||||
|
|
|
|
|||||
Adjusted EBITDA |
$ |
1,862 |
$ |
3,028 |
||||
|
|
|
|
(unaudited) |
||||||||||||||||
Total cash (used in) provided by: |
For the Nine Months Ended September 30, |
For the Year Ended December 31, |
||||||||||||||
(in thousands) |
2021 |
2020 |
2020 |
2019 |
||||||||||||
Operating activities |
$ | (22,099 | ) | $ | (4,320 | ) | $ | (9,146 | ) | $ | (10,928 | ) | ||||
Investing activities |
(220 | ) | 2,682 | 3,422 | (19,695 | ) | ||||||||||
Financing activities |
38,876 | 179 | 4,241 | 33,867 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash |
$ |
16,557 |
$ |
(1,459 |
) |
$ |
(1,483 |
) |
$ |
3,244 |
||||||
|
|
|
|
|
|
|
|
Payments Due By Period |
||||||||||||||||
As of December 31, 2020 (in thousands) |
Total |
Less than 1 year |
1-3 Years |
3-5 years |
||||||||||||
Operating lease obligations |
$ | 1,829 | $ | 525 | $ | 698 | $ | 606 | ||||||||
Line of credit |
3,910 | 3,910 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ |
5,739 |
$ |
4,435 |
$ |
698 |
$ |
606 |
||||||||
|
|
|
|
|
|
|
|
• | Level 1. Quoted prices in active markets for identical assets or liabilities. |
• | Level 2. Observable inputs other than Level 1 quoted prices, such as quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active for identical or similar assets and liabilities, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3. Valuations are based on inputs that are unobservable and significant to the overall fair value measurement of the assets or liabilities. Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. |
• | Offering a suite of products that help solve critical Member pain points, driving low acquisition costs. |
• | Creating frictionless access to a suite of financial products. |
• | Leveraging data to offer ExtraCash at unbeatable prices and speed to value. |
• | Focusing on community building with our Member base. |
• | Generating a “flywheel” by cross-selling existing Members to new products at no additional Member acquisition costs, resulting in lower consumer pricing. |
For Years Ended December 31, |
For Nine Months Ended September 30, |
|||||||||||||||
2019 |
2020 |
2020 |
2021 |
|||||||||||||
30-Day Repayment Rate |
95.9 | % | 95.4 | % | 96.0 | % | 95.8 | % |
• | Zero account minimums; |
• | 37,000 MoneyPass ATM network locations to make no-fee withdrawals; |
• | Paychecks delivered up to two days earlier than the scheduled payment date with direct deposit into the Dave Banking account, a feature accessible with no additional mandatory fees; |
• | Access to mobile wallets such as Apple Pay and Google Pay; |
• | Access to a free credit-building membership, where Members can build credit based on rent and utility payments made from their account; and |
• | Up to $200 in ExtraCash capacity for short-term emergencies. |
• | Service Revenue |
• | Insights (subscription fee) |
• | ExtraCash (optional instant transfer convenience fees and optional tips) |
• | Other (Side Hustle lead) |
• | Transaction Revenue |
• | Dave Banking (interchange fees, out-of-network |
• | Continue penetrating our large addressable market; |
• | Accelerate cross-sell into Dave Banking; |
• | Scale new Dave Banking Members; |
• | Deliver new products and features to cross-sell to Members; and |
• | Evaluate additional strategic acquisitions. |
• | Goals-Based Savings (“Goals”) : |
• | Peer-to-Peer : |
• | Banking Competitors non-bank digital providers that white-label regulated products, offering banking-related services (e.g., Chime). |
• | Lending and Earned Income Advance Competitors non-bank providers, offering consumer lending-related or advance products (e.g., Upstart, MoneyLion). |
• | Innovators in Consumer Finance |
• | Federal Trade Commission Act |
• | Truth in Savings Act. TISA . |
• | Electronic Fund Transfer Act and NACHA Rules EFTA NACHA non-recourse cash advances are performed by electronic fund transfers, including ACH transfers. We also facilitate the electronic transfer of funds requested by our Members between their deposit accounts with Evolve and their accounts at other financial institutions. |
• | Payday, Vehicle Title, and Certain High-Cost Installment Loans Final Rule |
• | Gramm-Leach-Bliley Act. GLBA |
Name |
Age |
Position | ||
Executive Officers |
||||
Jason Wilk | 36 | Chief Executive Officer, President and Director | ||
Kyle Beilman | 34 | Chief Financial Officer and Secretary | ||
Non-Employee Directors |
||||
Brendan Carroll | 44 | Director (1)(3) | ||
Andrea Mitchell | 50 | Director (2) (3) | ||
Michael Pope | 55 | Director (1) | ||
Dan Preston | 36 | Director (1)(2) |
(1) | Member of the audit committee. |
(2) | Member of the compensation committee. |
(3) | Member of the nominating and corporate governance committee. |
• | Class I, which consists of Michael Pope, whose term will expire at Dave’s first annual meeting of stockholders to be held in 2022; |
• | Class II, which consists of Dan Preston and Andrea Mitchell, whose terms will expire at Dave’s second annual meeting of stockholders to be held in 2023; and |
• | Class III, which consists of Jason Wilk and Brendan Carroll, whose terms will expire at Dave’s third annual meeting of stockholders to be held in 2024. |
• | appointing, compensating, retaining, evaluating, terminating and overseeing Dave’s independent registered public accounting firm; |
• | reviewing the adequacy of Dave’s system of internal controls and the disclosure regarding such system of internal controls contained in Dave’s periodic filings; |
• | pre-approving all audit and permitted non-audit services and related engagement fees and terms for services provided by Dave’s independent auditors; |
• | reviewing with Dave’s independent auditors their independence from management; |
• | reviewing, recommending and discussing various aspects of the financial statements and reporting of the financial statements with management and Dave’s independent auditors; and |
• | establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters. |
• | setting the compensation of the Chief Executive Officer and, in consultation with the Chief Executive Officer, reviewing and approving the compensation of the other executive officers of Dave; |
• | reviewing on a periodic basis and making recommendations regarding non-employee director compensation to the Board; |
• | reviewing on a periodic basis and discussing with the Chief Executive Officer and the Board regarding the development and succession plans for senior management positions; |
• | administering Dave’s cash and equity-based incentive plans that are stockholder-approved and/or where participants include Dave’s executive officers and directors; and |
• | providing oversight of and recommending improvements to Dave’s overall compensation and incentive plans and benefit programs. |
• | identifying, evaluating and making recommendations to the Board regarding nominees for election to the board of directors and its committees; |
• | developing and making recommendations to the Board regarding corporate governance guidelines and matters; |
• | overseeing the Dave’s corporate governance practices; |
• | reviewing the Dave’s code of business conduct and ethics and approve any amendments or waivers on a periodic basis; |
• | overseeing the evaluation and the performance of the Board and individual directors; and |
• | contributing to succession planning. |
• | for any transaction from which the director derives an improper personal benefit; |
• | for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | for any unlawful payment of dividends or redemption of shares; or |
• | for any breach of a director’s duty of loyalty to the corporation or its stockholders. |
• | Jason Wilk: Chief Executive Officer |
• | Kyle Beilman: Chief Financial Officer |
Name and Principal Position |
Year |
Salary ($) |
Bonus ($) |
Stock Awards ($) (1) |
Option Awards ($) (1) |
Non-Equity Incentive Plan Compensation ($) (2) |
All Other Compensation ($) |
Total ($) |
||||||||||||||||||||||||
Jason Wilk |
2021 | $ | 384,719 | — | (4) |
— | $ | 10,508,000 | — | $ | 13,654 | (5) |
$ | 10,906,373 | ||||||||||||||||||
Chief Executive Officer |
2020 | $ | 311,538 | $ | 42,750 | (3) |
— | — | $ | 92,250 | — | $ | 446,538 | |||||||||||||||||||
Kyle Beilman |
2021 | $ | 371,154 | — | (4) |
— | — | — | $ | 14,231 | (5) |
$ | 385,385 | |||||||||||||||||||
Chief Financial Officer |
2020 | $ | 311,538 | $ | 21,375 | (3) |
— | $ | 453,154 | $ | 46,125 | — | $ | 832,192 |
(1) | Stock awards and option awards are reported at aggregate grant date fair value in the year granted, as determined in accordance with the provisions of FASB ASC Topic 718. For the assumptions used in valuing these awards for purposes of computing this expense for 2021 and 2020, please see Note 14 of the Dave financial statements for the nine months ended September 30, 2021 and Note 1 of the Dave financial statements for the year ended December 31, 2020, respectively. |
(2) | Represents the annual performance cash bonus that, in each case, was earned by the named executive officers for the applicable year of service based on actual performance. Actual performance for the 2020 fiscal year was achieved at 61.5% of target performance. As of the date of this prospectus, the Board has not yet determined whether any bonuses will be awarded for the fiscal year ended December 31, 2021. |
(3) | Actual performance for the 2020 fiscal year was achieved at 61.5% of target performance. In consideration of the challenges posed by COVID-19 during the 2020 fiscal year, the Dave board of directors determined to adjust the annual performance payout for 2020 to 90% achievement of target performance. The amounts in this column represent the difference between the amount each named executive officer earned based on actual performance over the actual annual performance payout for 2020 assuming 90% achievement of target performance. |
(4) | As of the date of this prospectus, the Board has not yet determined whether any bonuses will be awarded for the fiscal year ended December 31, 2021. |
(5) | Represents Company matching contributions to the named executive officer’s contributions to the Company’s 401(k) plan. |
Metrics |
Target Performance |
Weighting |
Actual Achievement |
|||||||||
Non-GAAP Revenue (1) |
$ | 170,000,000 | 50 | % | 50.5 | % | ||||||
Non-GAAP Gross Margin(2) |
52.5 | % | 30 | % | 102.8 | % | ||||||
Banking TPV |
175,000,000 | 20 | % | 27.2 | % |
(1) | Non-GAAP revenue was calculated using GAAP service based revenue, adjusted for period-end revenue deferrals and processor costs associated with advance disbursements. |
(2) | Non-GAAP gross margin is non-GAAP gross profit divided by non-GAAP revenues. Non-GAAP gross profit was calculated using non-GAAP revenue, less processor costs associated with the disbursement and collection of advances and the provision for unrecoverable advances, calculated using actual unrecovered amounts for historical periods and assumed default amounts for periods where advance recoveries were still anticipated. |
Option awards (1) |
Stock awards (2) |
|||||||||||||||||||||||||||
Name |
Grant Date |
Number of securities underlying unexercised options exercisable (#) |
Number of securities underlying unexercised options unexercisable (#) |
Option exercise price ($) (3) |
Option expiration date ($) |
Number of shares that have not vested (#) |
Market value of shares that have not vested ($) (4) |
|||||||||||||||||||||
Jason Wilk |
3/3/2021 | — | 11,456,061 | $ | .0.72 | 3/2/2031 | — | — | ||||||||||||||||||||
Kyle Beilman |
11/14/2018 | (5) |
720,813 | 173,841 | $ | .04 | 11/13/2028 | |||||||||||||||||||||
3/3/2020 | (6) |
533,290 | (7) |
$ | 4,252,500 |
(1) | All stock options listed above cover shares of Class A Common Stock following the consummation of the Business Combination and were granted under the Legacy Dave Stock Plan. All stock options listed above are immediately exercisable upon the date of grant pursuant to an early exercise feature. |
(2) | All restricted shares listed above cover shares of Class A Common Stock following the Business Combination and were issued pursuant to the early exercise of stock options granted under the Legacy Dave Stock Plan. |
(3) | This column represents the fair market value of a share of Legacy Dave Common Stock on the date of grant, as determined by the Dave board of directors. |
(4) | This column represents the number of unvested restricted shares outstanding as of December 31, 2021, multiplied by $10.80, which is the per share value of Legacy Dave Common Stock as of December 31, 2021, divided by the exchange ratio of 1.354387513. |
(5) | The option grant is subject to a 4-year vesting schedule, with 25% of the shares vesting on July 15, 2019 and 1/48th of the shares vesting monthly thereafter, subject to the option holder’s continuous service through each vesting date. |
(6) | Represents the date the restricted stock was issued pursuant to early exercise of stock options. |
(7) | The restricted stock is subject to a 4-year vesting schedule, with 1/48th of the shares vesting on July 27, 2019 and monthly thereafter, subject to the option holder’s continuous service through each vesting date. The restricted stock was issued upon early exercise of a stock option granted on February 4, 2020. The restricted stock is also subject to acceleration in the event of a qualifying termination in connection with a change in control (as described below). |
Milestone Table | ||||
Tranche |
Stock Price Milestone |
Fraction of Total Shares Eligible to Vest | ||
1 |
Stock Price of $7.26 or more | 1/3 rd | ||
2 |
Stock Price of $10.89 or more | 1/12 th | ||
3 |
Stock Price of $14.52 or more | 1/12 th | ||
4 |
Stock Price of $18.15 or more | 1/12 th | ||
5 |
Stock Price of $21.78 or more | 1/12 th | ||
6 |
Stock Price of $25.41 or more | 1/12 th | ||
7 |
Stock Price of $29.04 or more | 1/12 th | ||
8 |
Stock Price of $32.67 or more | 1/12 th | ||
9 |
Stock Price of $36.30 or more | 1/12 th |
• | a transfer of all or substantially all of our company’s assets; |
• | a merger, consolidation or other capital reorganization or business combination transaction of our company with or into another corporation, entity or person; or |
• | the consummation of a transaction, or series of related transactions, in which any person becomes the beneficial owner, directly or indirectly, of more than 50% of our then outstanding capital stock; |
• | we, VPCC or Legacy Dave have been or are to be a participant; |
• | the amounts involved exceeded or exceeds $120,000; and |
• | any of our directors, executive officers or holders of more than 5% of our outstanding capital stock, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest. |
• | each person known by Dave to be the beneficial owner of more than 5% of the Common Stock; |
• | each of Dave’s executive officers and directors; and |
• | all executive officers and directors of Dave as a group. |
Name and Address of Beneficial Owners |
Number of shares of Class A Common Stock |
% |
Number of shares of Class V Common Stock |
% |
% of Total Voting Power |
|||||||||||||||
Five Percent Holders |
||||||||||||||||||||
Norwest Venture Partners XIV, LP (1) |
18,645,614 | 5.8 | % | — | — | 2.3 | % | |||||||||||||
Paras Chitrakar |
31,802,210 | 9.8 | % | — | — | 3.9 | % | |||||||||||||
Section 32 Fund 1, LP (2) |
98,114,926 | 30.3 | % | — | — | 12.1 | % | |||||||||||||
Current Directors and Named Executive Officers |
||||||||||||||||||||
Jason Wilk |
— | — | 48,450,639 | 100 | % | 60.0 | % | |||||||||||||
Kyle Beilman (3) |
3,430,338 | 1.1 | % | — | — | * | ||||||||||||||
Brendan Carroll |
— | — | — | — | — | |||||||||||||||
Andrea Mitchell |
— | — | — | — | — | |||||||||||||||
Michael Pope |
— | — | — | — | — | |||||||||||||||
Dan Preston (4) |
772,000 | * | — | — | * | |||||||||||||||
All executive officers and directors of the Combined Company as a group (6 individuals) |
4,202,338 | 1.3 | % | 48,450,639 | 100 | % | 62.5 | % |
* | Less than one percent. |
(1) | The general partner of Norwest Venture Partners XIV, L.P. is Genesis VC Partners XIV, LLC. The managing member of Genesis VC Partners XIV, LLC is NVP Associates, LLC. Promod Haque, Jeffrey Crowe and Jon Kossow are co-chief executive officers of NVP Associates, LLC. Each of these individuals has shared voting and investment power over the shares held by Norwest Venture Partners XIV, L.P. The address of Norwest Venture Partners XI, L.P. is 525 University Avenue, Suite 800, Palo Alto, CA 94301-1922. |
(2) | The general partner of Section 32 Fund 1, LP is Section 32 GP 1, LLC. The general partner of Section 32 Fund 1, LP, may be deemed to have voting and dispositive power over the shares held by Section 32 Fund 1, LP. Investment decisions with respect to the shares held by Section 32 Fund 1, LP are made by the managing member of Section 32 GP 1, LLC, William J. Maris, and, therefore, Mr. Maris may be deemed to be the beneficial owner of all shares held by Section 32 Fund 1, LP. Mr. Maris disclaims beneficial ownership of all shares held by Section 32 Fund 1, LP except to the extent of his pecuniary interest therein. The address for all entities and individuals affiliated with Section 32 Fund 1, LP is 171 Main St. #671, Los Altos, CA 94022. |
(3) | Consists of (a) 2,489,980 shares of Class A Common Stock and (b) 940,358 shares of Class A Common Stock issuable upon exercise of options within 60 days of the Closing Date. |
(4) | Consists of 772,000 shares of Class A Common Stock issuable upon exercise of options within 60 days of the Closing Date. |
Shares of Dave Class A Common Stock |
Private Warrants to Purchase Dave Class A Common Stock |
|||||||||||||||||||||||||||||||
Name |
Number Beneficially Owned Prior to Offering |
Number Registered for Sale Hereby |
Number Beneficially Owned After Offering |
Percent Owned After Offering |
Number Beneficially Owned Prior to Offering |
Number Registered for Sale Hereby |
Number Beneficially Owned After Offering |
Percent Owned After Offering |
||||||||||||||||||||||||
Alameda Research Ventures LLC (1) |
1,500,000 | 1,500,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Charles S Paul (2) |
16,100,524 | 16,100,524 | — | — | — | — | — | — | ||||||||||||||||||||||||
Clarence Jones |
2,595 | 2,595 | — | — | — | — | — | — | ||||||||||||||||||||||||
Dan Preston(3) |
772,000 | 772,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Funds advised by Corbin Capital Partners, L.P. (4) |
3,000,000 | 3,000,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Funds advised by Luxor Capital Group, LP (5) |
500,000 | 500,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Affiliates of Tiger Global Management, LLC (6) |
15,000,000 | 15,000,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Funds advised by Wellington Management Company LLP (7) |
1,000,000 | 1,000,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
JAK II LLC (8) |
6,830,122 | 6,830,122 | — | — | — | — | — | — | ||||||||||||||||||||||||
Janet Kloppenburg |
17,000 | 17,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Jason Wilk (9) |
59,906,700 | 59,906,700 | — | — | — | — | — | — | ||||||||||||||||||||||||
KPC Venture Capital LLC (10) |
5,238,791 | 5,238,791 | — | — | — | — | — | — | ||||||||||||||||||||||||
Kurt Summers |
17,000 | 17,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Kyna Payawal |
52,592 | 52,592 | — | — | — | — | — | — | ||||||||||||||||||||||||
Kyle Beilman (11) |
3,384,634 | 3,384,634 | — | — | — | — | — | — | ||||||||||||||||||||||||
Lauryn Nwankpa |
58,971 | 58,971 | — | — | — | — | — | — | ||||||||||||||||||||||||
Mark Cuban |
772,000 | 772,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Norwest Venture Partners XIV, LP (12) |
18,645,614 | 18,645,614 | — | — | — | — | — | — | ||||||||||||||||||||||||
Olivia Caggiano |
4,740 | 4,740 | — | — | — | — | — | — | ||||||||||||||||||||||||
Paras Chitrakar |
31,802,210 | 31,802,210 | — | — | — | — | — | — | ||||||||||||||||||||||||
Peter Offenhauser |
17,000 | 17,000 | — | — | — | — | — | — | ||||||||||||||||||||||||
Radical Investments LP (13) |
6,385,608 | 6,385,608 | — | — | — | — | — | — | ||||||||||||||||||||||||
Richard Fickling |
23,701 | 23,701 | — | — | — | — | — | — | ||||||||||||||||||||||||
Section 32 Fund 1, LP (14) |
98,114,926 | 98,114,926 | — | — | — | — | — | — | ||||||||||||||||||||||||
SV Angel VI LP (15) |
6,550,747 | 6,550,747 | — | — | — | — | — | — | ||||||||||||||||||||||||
TCG Digital, LLC (16) |
7,777,432 | 7,777,432 | — | — | — | — | — | — | ||||||||||||||||||||||||
The Jonathan A. Kraft 1996 Family Trust (17) |
1,091,155 | 1,091,155 | — | — | — | — | — | — | ||||||||||||||||||||||||
The Kiel Family Trust under the Jason Wilk 2021 Irrevocable Trust (18) |
913,859 | 913,859 | — | — | — | — | — | — | ||||||||||||||||||||||||
The Residual Trust under the Jason Wilk 2021 Irrevocable Trust (19) |
25,260,031 | 25,260,031 | — | — | — | — | — | — | ||||||||||||||||||||||||
The Wilk Family Trust under the Jason Wilk 2021 Irrevocable Trust (20) |
913,859 | 913,859 | — | — | — | — | — | — | ||||||||||||||||||||||||
Timur Minnakhmetov |
25,536 | 25,536 | — | — | — | — | — | — | ||||||||||||||||||||||||
TWO R LLC (21) |
2,939,501 | 2,939,501 | — | — | — | — | — | — | ||||||||||||||||||||||||
VPC Impact Acquisition Holdings Sponsor III (22) |
10,441,742 | 10,441,742 | — | — | 5,100,214 | 5,100,214 | — | — |
* | Represents beneficial ownership of less than 1%. |
(1) | Samuel Bankman-Fried has voting and investment control of the shares held by Alameda Research Ventures LLC and may be deemed to beneficially own the securities owned by Alameda Research Ventures LLC. |
(2) | Consists of (i) 772,000 shares of Dave Class A Common Stock held by Charles Paul and (ii) 15,328,524 shares of Dave Class A Common Stock held by the Charles S Paul Living Trust (the “Living Trust”), of which Mr. Paul is the trustee and has sole voting and investment power over such shares. As such, Mr. Paul may be deemed to be the beneficial owner of such shares. Mr. Paul disclaims any beneficial ownership of the shares held by the Living Trust, except to the extent of his pecuniary interest therein. Mr. Paul is a former director of Dave. |
(3) | Consists of 772,000 shares of Dave Class A Common Stock underlying Legacy Dave Options. |
(4) | Consists of (i) 1,230,000 shares of Dave Class A Common Stock held by Corbin ERISA Opportunity Fund, Ltd., (ii) 540,000 shares of Dave Class A Common Stock held by Corbin Opportunity Fund, L.P. and (iii) 1,230,000 shares of Dave Class A Common Stock held by Pinehurst Partners, L.P. Corbin Capital Partners, L.P. (“CCP”) is the investment manager of each of Corbin Opportunity Fund, L.P., Corbin ERISA Opportunity Fund, Ltd., and Pinehurst Partners, L.P. (collectively, the “Corbin Funds”). CCP and its general partner, Corbin Capital Partners GP, LLC, may be deemed beneficial owners of the Company securities being registered hereby for sale by the Corbin Funds. Craig Bergstrom, as the Chief Investment Officer of CCP, makes voting and investment decisions for the Corbin Funds, and may be deemed to beneficially own Dave Class A Common Stock owned directly by the Corbin Funds. The address for each of these entities and individuals is 590 Madison Avenue, 31st Floor, New York, NY 10022. |
(5) | Consists of (i) 187,736 shares of Dave Class A Common Stock held by Luxor Capital Partners Offshore Master Fund, LP (“Offshore Master Fund”) and (ii) 312,264 shares of Dave Class A Common Stock held by Luxor Capital Partners, LP (“Onshore Fund”). Luxor Capital Partners Offshore, Ltd. (“Offshore Feeder Fund”), as the owner of a controlling interest in Offshore Master Fund, may be deemed to beneficially own the securities owned directly by Offshore Master Fund. Each of LCG Holdings, LLC (“LCG Holdings”), and Luxor Capital Group, LP (“Luxor Capital Group”), as the general partner and investment manager, respectively, of Offshore Master Fund, may be deemed to beneficially own the securities owned directly by Offshore Master Fund. Luxor Management, LLC (“Luxor Management”), as the general partner of Luxor Capital Group, and Christian Leone, as the managing member of each of LCG Holdings and Luxor Management, may be deemed to beneficially own the securities owned directly by Offshore Master Fund. Each of LCG Holdings and Luxor Capital Group, as the general partner and investment manager, respectively, of Onshore Fund, may be deemed to beneficially own the securities owned directly by Onshore Fund. Luxor Management, as the general partner of Luxor Capital Group, and Christian Leone, as the managing member of each of LCG Holdings and Luxor Management, may be deemed to beneficially own Dave Class A Common Stock owned directly by Onshore Fund. The address for each of these entities and individuals is 1114 Avenue of the Americas, 28th Floor, New York, NY 10036. |
(6) | Consists of 15,000,000 shares of Dave Class A Common Stock held by Tiger Global Investments, L.P., Tiger Global Long Opportunities Master Fund, L.P. and/or certain persons and entities affiliated with Tiger Global Management, LLC. All such shares are controlled by Tiger Global Management, LLC, Chase Coleman and Scott Shleifer. The address for each of these entities and individuals is 9 West 57th Street, 35th Floor, New York, NY, 10019. |
(7) | Consists of (i) 114,405 shares of Dave Class A Common Stock held by Bay Pond Investors (Bermuda) L.P. (“Bay Pond Investors Bermuda”), (ii) 774,951 shares of Dave Class A Common Stock held by Bay Pond Partners, L.P. (“Bay Pond Partners”), and (iii) 110,644 shares of Dave Class A Common Stock held by Ithan Creek Master Investors (Cayman) L.P. (“Ithan Creek” and, together with Bay Pond Investors (Bermuda) and Bay Pond Partners, the “Wellington Funds”). Wellington Management Company LLP (“WMC”), as an investment adviser, has been delegated investment control and investment management authority (including voting) with respect to the Wellington Funds’ assets under management. WMC has the power to vote and dispose of the securities pursuant to WMC’s investment management relationship with the Wellington Funds. WMC is a subsidiary of Wellington Management Group LLP (“WMG”), a Massachusetts limited liability partnership that is privately held by 172 partners (as of July 1, 2020). No single partner owns or has the right to vote more than 5% of the partnership’s capital under management. |
(8) | Jonathan A. Kraft has voting and investment control of the shares held by JAK II LLC and may be deemed to beneficially own the securities owned directly by JAK II LLC. |
(9) | Consists of (i) 48,450,639 shares of Dave Class A Common Stock underlying shares of Dave Class V Common Stock and (ii) 11,456,061 shares of Dave Class A Common Stock underlying Legacy Dave Options. |
(10) | KPC Venture Capital LLC is managed by Chestnut Hill Management Corp. Each of Robert K. Kraft and Jonathan A. Kraft has voting and investment control of the shares held by KPC Venture Capital LLC and may be deemed to beneficially own the securities owned directly by KPC Venture Capital LLC. |
(11) | Consists of (i) 2,489,980 shares of Dave Class A Common Stock registered for resale under this prospectus and (ii) 894,654 shares of Dave Class A Common Stock underlying Legacy Dave Options. |
(12) | The general partner of Norwest Venture Partners XIV, L.P. is Genesis VC Partners XIV, LLC. The managing member of Genesis VC Partners XIV, LLC is NVP Associates, LLC. Promod Haque, Jeffrey Crowe and Jon Kossow are co-chief executive officers of NVP Associates, LLC. Each of these individuals has shared voting and investment power over the |
shares held by Norwest Venture Partners XIV, L.P. The address of Norwest Venture Partners XI, L.P. is 525 University Avenue, Suite 800, Palo Alto, CA 94301-1922. |
(13) | Radical Investments Management LLC, a Delaware limited liability company, is the sole general partner of Radical Investments LP. Both Radical Investments LP and Radical Investments Management LLC are beneficially owned by Mark Cuban and Mr. Cuban may be deemed to have voting and dispositive power over the securities held by Radical Investments LP. |
(14) | Section 32 GP 1, LLC, the general partner of Section 32 Fund 1, LP, may be deemed to have voting and dispositive power over the shares held by Section 32 Fund 1, LP. Investment decisions with respect to the shares held by Section 32 Fund 1, LP are made by the managing member of Section 32 GP 1, LLC, William J. Maris, and, therefore, Mr. Maris may be deemed to be the beneficial owner of all shares held by Section 32 Fund 1, LP. Mr. Maris disclaims beneficial ownership of all shares held by Section 32 Fund 1, LP except to the extent of his pecuniary interest therein. The address for all entities and individuals affiliated with Section 32 Fund 1, LP is 171 Main Street, #671, Los Altos, CA 94022. |
(15) | SV Angel VI LP is managed by SV Angel GP VI LLC. |
(16) | TCG Digital, LLC is managed by TCG, LLC, which is managed by The Chernin Group, LLC. |
(17) | The Jonathan A. Kraft 1996 Family Trust—Robert K. Kraft is the trustee for The Jonathan A. Kraft 1996 Family Trust and has sole voting and investment power over the shares of Dave Class A Common Stock held by The Jonathan A. Kraft 1996 Family Trust. As such, Mr. Kraft may be deemed to be the beneficial owner of such shares. |
(18) | The Kiel Family Trust under the Jason Wilk 2021 Irrevocable Trust is a corporate trust, with Premier Trust, Inc. appointed as the corporate trustee with investment authority. The address for the Kiel Family Trust under the Jason Wilk 2021 Irrevocable Trust is 4465 South Jones Boulevard, Las Vegas, NV 89103. |
(19) | The Residual Trust under the Jason Wilk 2021 Irrevocable Trust is a corporate trust, with Premier Trust, Inc. appointed as the corporate trustee with investment authority. The address for the Residual Trust under the Jason Wilk 2021 Irrevocable Trust is 4465 South Jones Boulevard, Las Vegas, NV 89103. |
(20) | The Wilk Family Trust under the Jason Wilk 2021 Irrevocable Trust is a corporate trust, with Premier Trust, Inc. appointed as the corporate trustee with investment authority. The address for the Wilk Family Trust under the Jason Wilk 2021 Irrevocable Trust is 4465 South Jones Boulevard, Las Vegas, NV 89103. |
(21) | Robert K. Kraft has voting and investment control of the shares held by TWO R LLC and may be deemed to beneficially own the securities owned directly by TWO R LLC. |
(22) | Consists of (i) 5,341,528 shares of Dave Class A Common Stock, (ii) 5,100,214 shares of Dave Class A Common Stock issuable upon exercise of Private Warrants and (iii) 5,100,214 Private Warrants. VPC Impact Acquisition Holdings Sponsor III, a Delaware LLC, is managed by Victory Park Management, LLC. Victory Park Management LLC is managed by Victory Park Capital Advisors, LLC, a Delaware limited liability company, which is managed by Jacob Capital, L.L.C., an Illinois limited liability company. Richard Levy is the sole member of Jacob Capital, L.L.C. and may be deemed to have beneficial ownership of Dave Class A Common Stock held directly by the Sponsor. |
• | 500,000,000 shares of Dave Class A Common Stock, $0.0001 par value per share; |
• | 100,000,000 shares of Dave Class V Common Stock, $0.0001 par value per share; and |
• | 10,000,000 shares of Preferred Stock, $0.0001 par value per share (“Preferred Stock”). |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption; and |
• | if, and only if, the last sale price of the Dave Class A Common Stock equals or exceeds $18.00 per share (as adjusted for share sub-divisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the table below, based on the redemption date and the “fair market value” (as defined below) of Dave Class A Common Stock except as otherwise described below; |
• | if, and only if, the closing price of Dave Class A Common Stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders; and |
• | if the closing price of Dave Class A Common Stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. |
• | the Board approved the acquisition prior to its consummation; |
• | the interested stockholder owned at least 85% of the outstanding voting stock upon consummation of the acquisition; or |
• | the business combination is approved by the Board, and by a 2/3 majority vote of the other stockholders in a meeting. |
• | 1% of the total number of shares of such Dave securities then-outstanding; or |
• | the average weekly reported trading volume of such Dave securities during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and materials required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Current Reports on Form 8-K; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
• | purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; |
• | ordinary brokerage transactions and transactions in which the broker solicits purchasers; |
• | block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
• | an over-the-counter |
• | through trading plans entered into by a Selling Securityholder pursuant to Rule 10b5-1 under the Exchange Act that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans; |
• | short sales; |
• | distribution to employees, members, limited partners or stockholders of the Selling Securityholders; |
• | through the writing or settlement of options or other hedging transaction, whether through an options exchange or otherwise; |
• | by pledge to secured debts and other obligations; |
• | delayed delivery arrangements; |
• | to or through underwriters or agents; |
• | in “at the market” offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents; |
• | in privately negotiated transactions; |
• | in options transactions; and |
• | through a combination of any of the above methods of sale, as described below, or any other method permitted pursuant to applicable law. |
• | an individual who is a United States citizen or resident of the United States; |
• | a corporation or other entity treated as a corporation for United States federal income tax purposes created in, or organized under the law of, the United States or any state or political subdivision thereof; |
• | an estate the income of which is includible in gross income for United States federal income tax purposes regardless of its source; or |
• | a trust (A) the administration of which is subject to the primary supervision of a United States court and which has one or more United States persons (within the meaning of the Code) who have the authority to control all substantial decisions of the trust or (B) that has in effect a valid election under applicable Treasury regulations to be treated as a United States person. |
• | the gain is effectively connected with the conduct of a trade or business by the non-U.S. Holder within the United States (and, if an applicable tax treaty so requires, is attributable to a U.S. permanent establishment or fixed base maintained by the non-U.S. Holder); |
• | the non-U.S. Holder is an individual who is present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met; or |
• | we are or have been a “United States real property holding corporation” for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the period that the non-U.S. Holder held our Dave Class A Common Stock or Dave Warrants and, in the case where shares of our Dave Class A Common Stock are regularly traded on an established securities market, the non-U.S. Holder has owned, directly or constructively, more than 5% of our Dave Class A Common Stock at any time within the shorter of the five-year period preceding the disposition or such Non-U.S. holder’s holding period for the shares of our Dave Class A Common Stock. There can be no assurance that our Dave Class A Common Stock will be treated as regularly traded on an established securities market for this purpose. |
Page |
||||
VPC IMPACT ACQUISITION HOLDINGS III, INC. |
||||
F-2 |
||||
F-3 | ||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 |
||||
F-17 |
||||
F-18 |
||||
F-19 |
||||
F-20 |
||||
F-21 |
Financial statements (unaudited) |
||||
F-41 | ||||
F-42 | ||||
F-43 | ||||
F-44 | ||||
F-45 | ||||
Financial statements (audited) |
||||
F-68 |
||||
Financial Statements: |
||||
F-69 |
||||
F-70 |
||||
F-71 |
||||
F-72 |
||||
F-73 |
ASSETS |
||||
Deferred offering costs |
$ | |||
TOTAL ASSETS |
$ | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||
Accrued expenses |
$ | |||
Accrued offering costs |
$ | |||
Total Current Liabilities |
||||
Commitments and Contingencies |
||||
Stockholders’ Equity |
||||
Preferred shares, $ |
||||
Class A common stock, $ |
||||
Class B common stock, $ (1) |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
Total Stockholders’ Equity |
||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
$ | |||
(1) | Includes up to |
Formation and operating costs |
$ | |||
Net loss |
$ |
( |
) | |
Weighted average shares outstanding, basic and diluted (1) |
||||
Basic and diluted net loss per common stock |
$ |
( |
) | |
(1) | Excludes |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance—January 14, 2021 (inception) |
$ | $ | $ | $ | ||||||||||||||||
Issuance of Class B common stock to Sponsor (1) |
||||||||||||||||||||
Net loss |
— | ( |
) | ( |
) | |||||||||||||||
Balance—January 22, 2021 |
$ |
$ |
$ |
( |
) |
$ |
||||||||||||||
(1) | Includes up to |
Cash Flows from Operating Activities: |
||||
Net loss |
$ | ( |
) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
Accrued Expense |
||||
Net cash used in operating activities |
||||
Net Change in Cash |
||||
Cash—Beginning of period |
||||
Cash—End of period |
$ | |||
Non-cash investing and financing activities: |
||||
Deferred offering costs included in accrued offering costs |
$ | |||
Deferred offering costs paid by Sponsor in exchange for the issuance of Class B common stock |
$ | |||
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the closing price of Class A common stock equals or exceeds $ |
• | in whole and not in part; |
• | at $ provided |
• | if, and only if, the closing price of Class A common stock equals or exceeds $ |
ASSETS |
||||
Current Assets |
||||
Cash |
$ | |||
Prepaid expenses |
||||
Total Current Assets |
||||
Investments held in Trust Account |
||||
Total Assets |
$ |
|||
LIABILITIES AND STOCKHOLDERS’ DEFICIT |
||||
Current Liabilities |
||||
Accrued expenses |
$ | |||
Total Current Liabilities |
||||
Warrant Liabilities |
||||
Deferred underwriting fee payable |
||||
Total Liabilities |
||||
Commitments |
||||
Class A common stock subject to possible redemption |
||||
Stockholders’ Deficit |
||||
Preferred stock, $ |
||||
Class A common stock, $ |
||||
Class B common stock, $ |
||||
Accumulated deficit |
( |
) | ||
Total Stockholders’ Deficit |
( |
) | ||
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
$ |
|||
Three Months Ended September 30, 2021 |
For The Period from January 14, 2021 (Inception) Through September 30, 2021 |
|||||||
Formation and operational costs |
$ | $ | ||||||
|
|
|
|
|||||
Loss from operations |
( |
) |
( |
) | ||||
Other expense: |
||||||||
Changes in fair value of warrant liability |
( |
) | ( |
) | ||||
Transaction costs allocated to warrant liabilities |
( |
) | ||||||
Interest earned on marketable securities held in Trust Account |
||||||||
|
|
|
|
|||||
Total other expense, net |
( |
) | ( |
) | ||||
Net loss |
$ |
( |
) |
$ |
( |
) | ||
|
|
|
|
|||||
Weighted average shares outstanding of Class A common stock |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per share, Class A |
$ |
( |
) |
$ |
( |
) | ||
|
|
|
|
|||||
Weighted average shares outstanding of Class B common stock(1) |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per share, Class B |
$ |
( |
) |
$ |
( |
) | ||
|
|
|
|
(1) | In connection with the underwriters’ partial exercise of the over-allotment option and the forfeiture of the remaining overallotment option on March 9, 2021, |
Class B Common Stock |
Additional Paid in Capital |
Accumulated Deficit |
Total Stockholder’s Deficit |
|||||||||||||||||
Shares |
Amount |
|||||||||||||||||||
Balance - January 14, 2021 (Inception) |
$ | $ | $ | $ | ||||||||||||||||
Issuance of Class B common stock to Sponsor(1) |
||||||||||||||||||||
Accretion for Class A common shares to redemption amount |
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||
Forfeiture of Founder Shares |
( |
) | ( |
) | ( |
) | ||||||||||||||
Net loss |
— | ( |
) | ( |
) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance - March 31, 2021 (unaudited) |
$ |
$ | $ |
( |
) |
$ |
( |
) | ||||||||||||
Net loss |
— | ( |
) | ( |
) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance - June 30, 2021 (unaudited) |
$ |
$ | $ |
( |
) |
$ |
( |
) | ||||||||||||
Net loss |
— | ( |
) | ( |
) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance - September 30, 2021 (unaudited) |
$ |
$ | $ |
( |
) |
$ |
( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) | In connection with the underwriters’ partial exercise of the over-allotment option and the forfeiture of the remaining overallotment option on March 9, 2021, |
Cash Flows from Operating Activities: |
||||
Net loss |
$ | ( |
) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
Interest earned on marketable securities held in Trust Account |
( |
) | ||
Changes in fair value of warrant liability |
||||
Transaction costs allocated to warrant liabilities |
||||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
( |
) | ||
Accrued expenses |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Investing Activities: |
||||
Investment of cash into Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash Flows from Financing Activities: |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||
Proceeds from sale of Private Placements Warrants |
||||
Repayment of promissory note - related party |
( |
) | ||
Payment of offering costs |
( |
) | ||
Net cash provided by financing activities |
||||
Net Change in Cash |
||||
Cash - Beginning of period |
||||
Cash - End of period |
$ |
|||
Non-cash investing and financing activities: |
||||
Offering costs paid by Sponsor in exchange for issuance of founder shares |
$ | |||
Offering costs paid through promissory note |
$ | |||
Deferred underwriting fee payable |
$ | |||
Forfeiture of Founder Shares |
$ | ( |
) | |
Balance Sheet as of March 9, 2021 (audited) |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Class A common stock subject to possible redemption |
$ | $ | $ | |||||||||
Class A common stock |
$ | $ | ( |
) | $ | |||||||
Additional paid-in capital |
$ | $ | ( |
) | $ | |||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total shareholders’ equity (deficit) |
$ | $ | ( |
) | $ | ( |
) |
Balance Sheet as of March 31, 2021 (unaudited) |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Class A common stock subject to possible redemption |
$ |
$ |
$ |
|||||||||
Class A common stock |
$ |
$ |
( |
) |
$ |
|||||||
Additional paid-in capital |
$ |
$ |
( |
) |
$ |
|||||||
Accumulated deficit |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Balance Sheet as of June 30, 2021 (unaudited) |
||||||||||||
Class A common stock subject to possible redemption |
$ |
$ |
$ |
|||||||||
Class A common stock |
$ |
$ |
( |
) |
$ |
|||||||
Additional paid-in capital |
$ |
$ |
( |
) |
$ |
|||||||
Accumulated deficit |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||
Total shareholders’ equity (deficit) |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Statement of Cash Flows for The Period from January 14, 2021 (Inception) Through March 31, 2021 (unaudited) |
||||||||||||
Initial classification of Class A common stock subject to possible redemption |
$ |
$ |
$ |
|||||||||
Change in value of Class A common stock subject to possible redemption |
$ |
$ |
( |
) |
$ |
|||||||
Statement of Cash Flows for The Period from January 14, 2021 (Inception) Through June 30, 2021 (unaudited) |
||||||||||||
Initial classification of Class A common stock subject to possible redemption |
$ |
$ |
$ |
|||||||||
Change in value of Class A common stock subject to possible redemption |
$ |
( |
) |
$ |
$ |
|||||||
Statement of Operations for The Period from January 14, 2021 (Inception) Through March 31, 2021 (unaudited) |
||||||||||||
Weighted average shares outstanding of Class A common stock redeemable shares |
( |
) |
||||||||||
Basic and diluted net loss per common share, Class A common stock redeemable shares |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Weighted average shares outstanding of Class B common stock non-redeemable shares |
||||||||||||
Basic and diluted net loss per common share, Class B common stock non-redeemable shares |
$ |
( |
) |
$ |
$ |
( |
) |
Statement of Operations for the three months ended June 30, 2021 (unaudited) |
As Previously Reported |
Adjustment |
As Restated |
|||||||||
Weighted average shares outstanding of Class A common stock redeemable shares |
||||||||||||
Basic and diluted net loss per common share, Class A common stock redeemable shares |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Weighted average shares outstanding of Class B common stock non-redeemable shares |
||||||||||||
Basic and diluted net loss per common share, Class B common stock non-redeemable shares |
$ |
( |
) |
$ |
$ |
( |
) | |||||
Statement of Operations for The Period from January 14, 2021 (Inception) Through June 30, 2021 |
||||||||||||
Weighted average shares outstanding of Class A common stock redeemable shares |
( |
) |
||||||||||
Basic and diluted net loss per common share, Class A common stock redeemable shares |
$ |
$ |
( |
) |
$ |
( |
) | |||||
Weighted average shares outstanding of Class B common stock non-redeemable shares |
( |
) |
||||||||||
Basic and diluted net loss per common share, Class B common stock non-redeemable shares |
$ |
( |
) |
$ |
$ |
( |
) |
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
$ | ( |
) | |
Class A common stock issuance costs |
$ | ( |
) | |
Plus: |
||||
Accretion of carrying value to redemption value |
$ | |||
Class A common stock subject to possible redemption |
$ |
Three Months Ended September 30, 2021 |
For the Period from January 14, 2021 (Inception) Through September 30, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net loss per common shares |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net loss, as adjusted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average common shares outstanding |
||||||||||||||||
Basic and diluted net loss per common shares |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) |
• |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of |
• | if, and only if, the closing price of Class A common stock equals or exceeds $ a period ending on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• |
in whole and not in part; |
• |
at $ provided |
• |
if, and only if, the closing price of Class A common stock equals or exceeds $ the |
Description |
September 30, 2021 |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
||||||||||||
Assets: |
||||||||||||||||
Investments held in Trust Account - U.S. Treasury Securities Money Market Fund |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Liabilities: |
||||||||||||||||
Warrant Liability - Public Warrants |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Warrant Liability - Private Placement Warrants |
$ |
$ |
$ |
$ |
||||||||||||
|
|
|
|
|
|
|
|
January 12, 2021 |
||||||||||||
(Initial Measurement) |
September 30, 2021 |
|||||||||||
Public |
Private |
Private |
||||||||||
Input |
Warrants |
Warrants |
Warrants |
|||||||||
Stock Price |
$ |
$ |
$ |
|||||||||
Exercise Price |
$ |
$ |
$ |
|||||||||
Volatility |
% |
% |
% | |||||||||
Term (years) |
||||||||||||
Dividend Yield |
% |
% |
% | |||||||||
Risk Free Rate |
% |
% |
% |
Private Placement |
||||
Fair value as of January 14, 2021 (inception) |
$ |
|||
Initial measurement on March 9, 2021 |
||||
Change in valuation inputs or other assumptions |
( |
) | ||
Transfer to Level 1 |
||||
Fair value as of March 31, 2021 |
$ |
|||
Change in valuation inputs or other assumptions |
||||
Fair value as of June 30, 2021 |
$ |
|||
Change in valuation inputs or other assumptions |
||||
Fair value as of September 30, 2021 |
$ |
Dave Inc. Condensed Consolidated Balance Sheets (in thousands; except share data) |
||||||||
As of September 30, |
As of December 31, |
|||||||
2021 |
2020 |
|||||||
(unaudited) |
(as restated) |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Marketable securities |
||||||||
Member 2020, respectively |
||||||||
Prepaid income taxes |
||||||||
Restricted cash, current |
||||||||
Deferred issuance costs |
||||||||
Prepaid expenses and other current assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Lease right-of-use |
||||||||
Intangible assets, net |
||||||||
Derivative asset on loans to stockholders |
||||||||
Debt facility commitment fee, long-term |
||||||||
Restricted cash, net of current portion |
||||||||
|
|
|
|
|||||
Total assets |
$ |
$ |
||||||
|
|
|
|
|||||
Liabilities, convertible preferred stock, and stockholders’ deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Line of credit |
||||||||
Lease liabilities, short-term (related-party of $ |
||||||||
Legal settlement accrual |
||||||||
Note payable |
||||||||
Other current liabilities |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Lease liabilities, long-term (related-party of $ |
||||||||
Long-term debt facility |
||||||||
Convertible debt, long-term |
||||||||
Interest payable, convertible notes |
||||||||
Warrant liability |
||||||||
Other non-current liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies (Note 8) |
||||||||
Convertible preferred stock |
||||||||
Series A convertible preferred stock, par value per share $ |
||||||||
Series B-1 convertible preferred stock, par value per share $ |
||||||||
Series B-2 convertible preferred stock, par value per share $ |
||||||||
|
|
|
|
|||||
Total convertible preferred stock |
||||||||
|
|
|
|
|||||
Stockholders’ deficit: |
||||||||
Common stock, par value per share $ |
||||||||
Treasury stock |
( |
) | ( |
) | ||||
Additional paid-in capital |
||||||||
Loans to stockholders |
( |
) | ( |
) | ||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total stockholders’ deficit |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Total liabilities, convertible preferred stock, and stockholders’ deficit |
$ |
$ |
||||||
|
|
|
|
Dave Inc. Condensed Consolidated Statements of Operations (in thousands, except per share data) (unaudited) |
||||||||
For the Nine Months Ended September 30, |
||||||||
2021 |
2020 |
|||||||
Operating revenues: |
||||||||
Service based revenue, net |
$ | $ | ||||||
Transaction based revenue, net |
||||||||
|
|
|
|
|||||
Total operating revenues, net |
||||||||
|
|
|
|
|||||
Operating expenses: |
||||||||
Provision for unrecoverable advances |
||||||||
Processing and servicing fees |
||||||||
Advertising and marketing |
||||||||
Compensation and benefits |
||||||||
Other operating expenses |
||||||||
|
|
|
|
|||||
Total operating expenses |
||||||||
|
|
|
|
|||||
Other (income) expenses: |
||||||||
Interest income |
( |
) | ( |
) | ||||
Interest expense |
||||||||
Legal settlement and litigation expenses |
||||||||
Other strategic financing and transactional expenses |
||||||||
Derivative asset on loans to stockholders |
( |
) | ||||||
Changes in fair value of warrant liability |
||||||||
|
|
|
|
|||||
Total other (income) expense, net |
( |
) |
||||||
|
|
|
|
|||||
Net (loss) income before provision for income taxes |
( |
) |
||||||
Income tax benefit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net (loss) income |
$ |
( |
) |
$ |
||||
|
|
|
|
|||||
Net (loss) income per share: |
||||||||
Basic |
$ | ( |
) | $ | ||||
Diluted |
$ | ( |
) | $ | ||||
Weighted-average shares used to compute net (loss) income per share |
||||||||
Basic |
||||||||
Diluted |
Series A convertible preferred stock |
Series B-1 convertiblepreferred stock |
Series B-2 convertiblepreferred stock |
Common stock |
Additional paid-in capital |
Loans to stockholders |
Treasury stock |
Accumulated deficit |
Total stockholders’ deficit |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2020 |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock for stock option exercises |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||
Vesting of stock option early exercises |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Stockholder loans |
— | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||||||||||
Balance at September 30, 2021 |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||||||||||||||||||||||||||
Series A convertible preferred stock |
Series B-1 convertiblepreferred stock |
Series B-2 convertiblepreferred stock |
Common stock |
Additional paid-in capital |
Loans to stockholders |
Treasury stock |
Accumulated (deficit) retained earnings |
Total stockholders’ (deficit) equity |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2019 |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | ||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock for stock option exercises |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock for stock option early exercises |
— | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||
Stockholder loans interest |
— | — | — | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Net income |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||||||||
Balance at September 30, 2020 |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
$ |
|||||||||||||||||||||||||||||||||||||||||||||||
For the Nine Months Ended September 30, |
||||||||
2021 |
2020 |
|||||||
Operating activities |
||||||||
Net (loss) income |
$ | ( |
) | $ | ||||
Adjustments to reconcile net (loss) income to net cash used in operating activities: |
||||||||
Depreciation and amortization |
||||||||
Provision for unrecoverable advances |
||||||||
Changes in fair value of derivative assets |
( |
) | ||||||
Changes in fair value of warrant liability |
||||||||
Stock-based compensation |
||||||||
Non-cash interest expense |
( |
) | ( |
) | ||||
Non-cash lease expense |
||||||||
Changes in fair value of marketable securities |
( |
) | ||||||
Changes in operating assets and liabilities: |
||||||||
Member advances |
( |
) | ( |
) | ||||
Prepaid income taxes |
( |
) | ||||||
Prepaid expenses and other current assets |
( |
) | ||||||
Accounts payable |
( |
) | ||||||
Accrued expenses |
||||||||
Income taxes payable |
( |
) | ||||||
Other current liabilities |
( |
) | ||||||
Other non-current liabilities |
( |
) | ||||||
Deferred tax asset |
( |
) | ||||||
Interest payable, convertible notes |
||||||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
Investing activities |
||||||||
Payments for internally developed software costs |
( |
) | ( |
) | ||||
Purchase of property and equipment |
( |
) | ( |
) | ||||
Purchase of marketable securities |
( |
) | ( |
) | ||||
Sale of marketable securities |
||||||||
Net cash (used in) provided by investing activities |
( |
) |
||||||
Financing activities |
||||||||
Repayment on line of credit |
( |
) | ||||||
Proceeds from issuance of common stock for stock option exercises |
||||||||
Payment of issuance costs |
( |
) | ||||||
Proceeds from borrowings |
||||||||
Net cash provided by financing activities |
||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash |
( |
) | ||||||
Cash and cash equivalents and restricted cash, beginning of period |
||||||||
Cash and cash equivalents and restricted cash, end of period |
$ |
$ |
||||||
Supplemental disclosure of non-cash investing and financing activities |
||||||||
Operating lease right of use assets recognized |
$ | $ | ||||||
Operating lease liabilities recognized |
$ | $ | ||||||
Property and equipment purchases in accounts payable |
$ | $ | ||||||
Amendment to loan to stockholder |
$ | $ | ||||||
Supplemental disclosure of cash (received) paid for: |
||||||||
Income taxes |
$ | ( |
) | $ | ||||
Interest |
$ | $ | ||||||
The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the condensed consolidated balance sheet with the same as shown in the condensed consolidated statement of cash flows. |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash |
||||||||
Total cash, cash equivalents, and restricted cash, end of period |
$ |
$ |
||||||
Assets |
||||
Cash and cash equivalents |
$ | |||
Member advances, net of allowance for unrecoverable advances of $ |
||||
Debt facility commitment fee, current |
||||
Debt facility commitment fee, long-term |
||||
Total assets |
$ |
|||
Liabilities and stockholder’s deficit |
||||
Long-term debt facility |
$ | |||
Warrant liability |
||||
Equity contributed |
||||
Accumulated deficit |
( |
) | ||
Total liabilities and stockholder’s deficit |
$ |
|||
September 30, 2021 |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||
Assets |
||||||||||||||||
Marketable securities |
$ | $ | $ | $ | ||||||||||||
Derivative asset on loans to stockholders |
||||||||||||||||
Total assets |
$ |
$ |
$ |
$ |
||||||||||||
Liabilities |
||||||||||||||||
Warrant liability |
$ | $ | $ | $ | ||||||||||||
Note payable |
||||||||||||||||
Total liabilities |
$ |
$ |
$ |
$ |
||||||||||||
December 31, 2020 |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||
Assets |
||||||||||||||||
Marketable securities |
$ | $ | $ | $ | ||||||||||||
Derivative asset on loans to stockholders |
||||||||||||||||
Total assets |
$ |
$ |
$ |
$ |
||||||||||||
Ending value at December 31, 2019 |
$ |
|||
Change in fair value during the period |
||||
Ending value at December 31, 2020 |
||||
Amendment to loan to stockholder |
||||
Change in fair value during the period |
||||
Ending value at September 30, 2021 |
$ |
|||
Expected volatility |
||
Risk-free interest rate |
||
Remaining term |
Opening value at December 31, 2020 |
$ |
|||
Initial fair value at the original issuance date |
||||
Change in fair value during the period |
||||
Ending value at September 30, 2021 |
$ |
|||
Expected volatility |
||
Risk-free interest rate |
||
Remaining term |
Opening value at December 31, 2020 |
$ |
|||
Initial fair value at the original issuance date |
||||
Change in fair value during the period |
||||
Ending value at September 30, 2021 |
$ |
|||
• | Historical financial performance; |
• | The Company’s business strategy; |
• | Industry information, such as external market conditions and trends; |
• | Lack of marketability of the Common Stock; |
• | Likelihood of achieving a liquidity event, such as an initial public offering, special-purpose acquisition company (“SPAC”) merger, or strategic sale given prevailing market conditions and the nature and history of the Company’s business; |
• | Prices, privileges, powers, preferences, and rights of our convertible preferred stock relative to those of the Common Stock; |
• | Forecasted cash flow projections for the Company; |
• | Illiquidity of stock-based awards involving securities in a private company; and |
• | Macroeconomic conditions. |
For the Nine Months September 30, |
||||||||
2021 |
2020 |
|||||||
(unaudited) |
||||||||
Numerator |
||||||||
Net (loss) income |
$ | ( |
) | $ | ||||
Less: noncumulative dividend to convertible preferred stockholders |
( |
) | ||||||
Less: undistributed earnings to participating securities |
— | ( |
) | |||||
Net (loss) income attributed to common stockholders—Basic |
( |
) | ||||||
Add: undistributed earnings reallocated to common stockholders |
— | |||||||
Net (loss) income attributed to common stockholders—Diluted |
$ | ( |
) | $ | ||||
Denominator |
||||||||
Weighted average shares of common stock—basic |
||||||||
Dilutive effect of equity incentive awards |
||||||||
Weighted average shares of common stock—diluted |
||||||||
Net (loss) income per share |
||||||||
Basic |
$ | ( |
) | $ | ||||
Diluted |
$ | ( |
) | $ |
For the Nine Months September 30, |
||||||||
2021 |
2020 |
|||||||
(unaudited) |
||||||||
Equity incentive awards |
||||||||
Convertible preferred stock |
||||||||
Series B-1 warrants |
— | |||||||
Total |
||||||||
Days From Origination |
Gross Member Advances |
Allowance for Unrecoverable Advances |
Member Advances, Net |
|||||||||
(unaudited) |
(unaudited) |
(unaudited) |
||||||||||
1-10 |
$ | $ | ( |
) | $ | |||||||
11-30 |
( |
) | ||||||||||
31-60 |
( |
) | ||||||||||
61-90 |
( |
) | ||||||||||
91-120 |
( |
) | ||||||||||
Total |
$ |
$ |
( |
) |
$ |
|||||||
Days From Origination |
Gross Member Advances |
Allowance for Unrecoverable Advances |
Member Advances, Net |
|||||||||
1-10 |
$ | $ | ( |
) | $ | |||||||
11-30 |
( |
) | ||||||||||
31-60 |
( |
) | ||||||||||
61-90 |
( |
) | ||||||||||
91-120 |
( |
) | ||||||||||
Total |
$ |
$ |
( |
) |
$ |
|||||||
Ending allowance balance at December 31, 2020 |
$ |
|||
Plus: provision for unrecoverable advances |
||||
Less: amounts written-off |
( |
) | ||
Ending allowance balance at September 30, 2021 (unaudited) |
$ |
|||
Ending allowance balance at December 31, 2019 |
$ |
|||
Plus: provision for unrecoverable advances |
||||
Less: amounts written-off |
( |
) | ||
Ending allowance balance at September 30, 2020 (unaudited) |
$ |
|||
(unaudited) September 30, 2021 |
December 31, 2020 |
|||||||
Accrued charitable contributions |
$ | $ | ||||||
Accrued compensation |
||||||||
Sales tax payable |
||||||||
Other |
||||||||
Total |
$ |
$ |
||||||
Expected volatility |
% | |||
Risk-free interest rate |
% | |||
Remaining term |
For the Nine Months Ended September 30, 2021 |
||||
Operating lease cost |
$ | |||
Short-term lease cost |
||||
Variable lease cost |
||||
Total lease cost |
$ |
|||
Other information: |
||||
Cash paid for operating leases |
$ | |||
Right-of-use |
$ | |||
Weighted-average remaining lease term—operating lease |
||||
Weighted-average discount rate—operating lease |
% |
Year |
3rd-Party Commitment |
Related- Party Commitment |
Total |
|||||||||
2021 (remaining) |
$ | $ | $ | |||||||||
2022 |
||||||||||||
2023 |
||||||||||||
2024 |
||||||||||||
2025 |
||||||||||||
Thereafter |
||||||||||||
Total minimum lease payments |
$ |
$ |
$ |
|||||||||
Less: imputed interest |
( |
) | ( |
) | ( |
) | ||||||
Total lease liabilities |
$ |
$ |
$ |
|||||||||
(unaudited) |
||||||||||||||||||||
As of September 30, 2021 |
||||||||||||||||||||
Authorized Shares |
Issued Shares |
Outstanding Shares |
Liquidation Preference (in thousands) |
Carrying Value (in thousands) |
||||||||||||||||
Series A Preferred Shares |
$ | $ | ||||||||||||||||||
Series B-1 Preferred Shares |
$ | $ | ||||||||||||||||||
Series B-2 Preferred Shares |
$ | $ | ||||||||||||||||||
Common Stock |
$ | — | $ | |||||||||||||||||
As of December 31, 2020 |
||||||||||||||||||||
Authorized Shares |
Issued Shares |
Outstanding Shares |
Liquidation Preference (in thousands) |
Carrying Value (in thousands) |
||||||||||||||||
Series A Preferred Shares |
$ | $ | ||||||||||||||||||
Series B-1 Preferred Shares |
$ | $ | ||||||||||||||||||
Series B-2 Preferred Shares |
$ | $ | ||||||||||||||||||
Common Stock |
$ | — | $ |
Shares |
Weighted-Average Exercise Price |
|||||||
Options outstanding, December 31, 2020 |
$ | |||||||
Granted |
$ | |||||||
Exercised |
( |
) | $ | |||||
Forfeited |
( |
) | $ | |||||
Expired |
( |
) | $ | |||||
Options outstanding, September 30, 2021, unaudited |
$ | |||||||
Expected volatility |
% | |||
Risk-free interest rate |
% | |||
Remaining term |
||||
Expected dividend yield |
% |
Shares |
Weighted-Average Grant-Date Fair Value |
|||||||
Nonvested shares at December 31, 2020 |
$ | |||||||
Granted |
$ | |||||||
Vested |
( |
) | $ | |||||
Forfeited |
$ | |||||||
Nonvested shares at September 30, 2021, unaudited |
$ |
|||||||
Shares |
Weighted-Average Grant-Date Fair Value |
|||||||
Nonvested shares at December 31, 2020 |
$ | |||||||
Granted |
$ | |||||||
Vested |
( |
) | $ | |||||
Forfeited |
$ | |||||||
Nonvested shares at September 30, 2021, unaudited |
$ | |||||||
Year |
Related-Party Commitment |
|||
2021 (remaining) |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total minimum lease payments |
$ |
|||
Less: imputed interest |
( |
) | ||
Total lease liabilities |
$ |
|||
As of December 31, |
||||||||
2020 |
2019 |
|||||||
As Restated |
As Restated |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Marketable securities |
||||||||
Member advances, net of allowance for unrecoverable advances of $ |
||||||||
Prepaid income taxes |
||||||||
Restricted cash, current |
||||||||
Prepaid expenses and other current assets |
||||||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Lease right-of-use |
||||||||
Intangible assets, net |
||||||||
Derivative asset on loans to stockholders |
||||||||
Restricted cash |
||||||||
Total assets |
$ |
$ |
||||||
Liabilities, convertible preferred stock, and stockholders’ deficit |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Line of credit |
||||||||
Lease liabilities, short-term (related party of $ |
||||||||
Income taxes payable |
||||||||
Legal settlement accrual |
||||||||
Other current liabilities |
||||||||
Total current liabilities |
||||||||
Lease liabilities, long-term (related party of $ |
||||||||
Convertible debt, long-term |
||||||||
Interest payable, convertible notes |
||||||||
Other non-current liabilities |
||||||||
Total liabilities |
||||||||
Commitments and contingencies (Note 11) |
||||||||
Convertible preferred stock |
||||||||
Series A convertible preferred stock, par value per share $ |
||||||||
Series B-1 convertible preferred stock, par value per share $ |
||||||||
Series B-2 convertible preferred stock, par value per share $ |
||||||||
Total convertible preferred stock |
||||||||
Stockholders’ deficit: |
||||||||
Common stock, par value per share $ |
||||||||
Treasury stock |
( |
) | ( |
) | ||||
Additional paid-in capital |
||||||||
Loans to stockholders |
( |
) | ( |
) | ||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total stockholders’ deficit |
( |
) |
( |
) | ||||
Total liabilities, convertible preferred stock, and stockholders’ deficit |
$ |
$ |
||||||
For the Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
As Restated |
As Restated |
|||||||
Operating revenues: |
||||||||
Service based revenue, net |
$ | $ | ||||||
Transaction based revenue, net |
||||||||
Total operating revenues, net |
||||||||
Operating expenses: |
||||||||
Provision for unrecoverable advances |
||||||||
Processing and servicing fees |
||||||||
Advertising and marketing |
||||||||
Compensation and benefits |
||||||||
Other operating expenses |
||||||||
Total operating expenses |
||||||||
Other (income) expense: |
||||||||
Interest income |
( |
) | ( |
) | ||||
Interest expense |
||||||||
Gain on conversion of 2018 convertible notes |
( |
) | ||||||
Derivative liability |
||||||||
Legal settlement and litigation expenses |
||||||||
Other strategic financing and transactional expenses |
||||||||
Total other expenses, net |
||||||||
Net (loss) income before provision for income taxes |
( |
) |
||||||
Provision for income taxes |
||||||||
Net (loss) income |
$ |
( |
) |
$ |
||||
Net (loss) income per share: |
||||||||
Basic |
$ | ( |
) | $ | ||||
Diluted |
$ | ( |
) | $ | ||||
Weighted-average shares used to compute net income (loss) per share |
||||||||
Basic |
||||||||
Diluted |
Series A convertible preferred stock |
Series B-1 convertible preferred stock |
Series B-2 convertible preferred stock |
Common stock |
Additional paid-in capital |
Loans to stockholders |
Treasury stock |
Accumulated deficit |
Total stockholders’ deficit |
||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||
Balance at January 1, 2019 |
$ |
$ |
$ |
$ |
$ |
$ |
— |
$ |
— |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||||||||||||||||||||
Issuance of restricted stock |
— | — | — | — | — | — | — | — | — | — | — | — |
||||||||||||||||||||||||||||||||||||||||
Cancellation of restricted stock |
— | — | — | — | — | — | ( |
) | — | — | — | — | — | — |
||||||||||||||||||||||||||||||||||||||
Issuance of common stock for stock option exercises |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Issuance of series B-1 convertible preferred stock, net of issuance costs of $325 thousand |
— | — | — | — | — | — | — | — | — | — | — |
|||||||||||||||||||||||||||||||||||||||||
Conversion of notes and accrued interest to series B-2 preferred stock |
— | — | — | — | — | — | — | — | — | — | — |
|||||||||||||||||||||||||||||||||||||||||
Treasury stock |
— | — | — | — | — | — | ( |
) | — | — | — | ( |
) | — | ( |
) | ||||||||||||||||||||||||||||||||||||
Stockholder loans |
— | — | — | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||
Stock-based compensation—restricted stock |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Stock-based compensation—stock options |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Net income as restated |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2019 as restated |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||||||||||||||||||
Issuance of common stock for stock option exercises |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||||
Issuance of common stock for stock option early exercises |
— | — | — | — | — | — | — | — | — | — | — | — |
||||||||||||||||||||||||||||||||||||||||
Cancellation of common stock issued for stock option early exercise |
— | — | — | — | — | — | ( |
) | — | — | — | — | — | — |
||||||||||||||||||||||||||||||||||||||
Cancellation of restricted stock |
— | — | — | — | — | — | ( |
) | — | — | — | — | — | — |
||||||||||||||||||||||||||||||||||||||
Stockholder loans interest |
— | — | — | — | — | — | — | — | — | ( |
) | — | — | ( |
) | |||||||||||||||||||||||||||||||||||||
Stock-based compensation—restricted stock |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Stock-based compensation—stock options |
— | — | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Net loss as restated |
— | — | — | — | — | — | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||||
Balance at December 31, 2020 as restated |
$ |
$ |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||||||||||||||||||
For the Years Ended December 31, |
||||||||
2020 |
2019 |
|||||||
As Restated |
As Restated |
|||||||
Operating activities |
||||||||
Net (loss) income |
$ | ( |
) | $ | ||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Depreciation and amortization |
||||||||
Provision for unrecoverable advances |
||||||||
Stock-based compensation—restricted stock |
||||||||
Stock-based compensation—stock options |
||||||||
Non-cash interest from loans to stockholders |
( |
) | ( |
) | ||||
Non-cash lease expense |
||||||||
Changes in fair value of marketable securities |
( |
) | ( |
) | ||||
Changes in fair value of derivative assets and liabilities |
— | |||||||
Gain on conversion of 2018 convertible notes |
( |
) | ||||||
Accretion of debt discount |
||||||||
Changes in operating assets and liabilities: |
||||||||
Member advances |
( |
) | ( |
) | ||||
Prepaid income taxes |
( |
) | ||||||
Prepaid expenses and other current assets |
( |
) | ( |
) | ||||
Accounts payable |
||||||||
Accrued expenses |
||||||||
Income taxes payable |
( |
) | ||||||
Legal settlement accrual |
||||||||
Other current liabilities |
||||||||
Other non-current liabilities |
||||||||
Interest payable, convertible notes |
||||||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
Investing activities |
||||||||
Payments for internally developed software costs |
( |
) | ( |
) | ||||
Purchase of derivative asset on loans to stockholders |
( |
) | ||||||
Purchase of property and equipment |
( |
) | ( |
) | ||||
Sale of marketable securities |
||||||||
Purchase of marketable securities |
( |
) | ( |
) | ||||
Net cash provided by (used in) investing activities |
( |
) | ||||||
Financing activities |
||||||||
Repayment of convertible debt |
( |
) | ||||||
Loans to stockholders |
( |
) | ||||||
Acquisition of treasury stock |
( |
) | ||||||
Borrowings on line of credit |
||||||||
Repayment on line of credit |
( |
) | ||||||
Proceeds from issuance of common stock for stock option exercises |
||||||||
Proceeds from issuance of common stock for stock option early exercises |
||||||||
Proceeds from issuance of preferred stock |
||||||||
Proceeds from issuance of convertible debt |
||||||||
Net cash provided by financing activities |
||||||||
Net (decrease) increase in cash and cash equivalents and restricted cash |
( |
) | ||||||
Cash and cash equivalents and restricted cash, beginning of year |
||||||||
Cash and cash equivalents and restricted cash, end of year |
$ |
$ |
||||||
Supplemental disclosure of non-cash investing and financing activities |
||||||||
2018 convertible notes and derivative liability settled with preferred shares |
$ | $ | ||||||
Operating lease right of use assets recognized |
$ | $ | ||||||
Operating lease liabilities recognized |
$ | $ | ||||||
Property and equipment purchases in accounts payable |
$ | $ | ||||||
Receivable from early exercise of stock options |
$ | $ | ||||||
Supplemental disclosure of cash paid for: |
||||||||
Income taxes |
$ | $ | ||||||
Interest |
$ | $ | ||||||
The following table provides a reconciliation of cash and cash equivalents, and restricted cash reported within the consolidated balance sheets with the same as shown in the consolidated statements of cash flows. | ||||||||
Cash and cash equivalents |
$ | $ | ||||||
Restricted cash |
||||||||
Total cash, cash equivalents, and restricted cash, end of year |
$ | $ | ||||||
As of December 31, |
||||||||||||
2020 |
||||||||||||
Consolidated Balance Sheet: |
As Reported |
Adjustments |
As Restated |
|||||||||
Assets |
||||||||||||
Member advances, net of allowance for unrecoverable advances |
$ | $ | ( |
) | $ | |||||||
Prepaid income taxes |
$ | $ | $ | |||||||||
Total current assets |
$ | $ | ( |
) | $ | |||||||
Total assets |
$ | $ | ( |
) | $ | |||||||
Liabilities, convertible preferred stock, and stockholders’ deficit |
||||||||||||
Other non-current liabilities |
$ | $ | ( |
) | $ | |||||||
Total liabilities |
$ | $ | ( |
) | $ | |||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total stockholders’ deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total liabilities, convertible preferred stock, and stockholders’ deficit |
$ | $ | ( |
) | $ |
For the year ended December 31, |
||||||||||||
2020 |
||||||||||||
Consolidated Statement of Operations |
As Reported |
Adjustments |
As Restated |
|||||||||
Provision for unrecoverable advances |
$ | $ | $ | |||||||||
Total operating expenses |
$ | $ | $ | |||||||||
Net loss before provision for income taxes |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Provision for income taxes |
$ | $ | ( |
) | $ | |||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Net loss per share: |
||||||||||||
Basic |
$ | ( |
) | $ | ( |
) | ||||||
Diluted |
$ | ( |
) | $ | ( |
) |
For the year ended December 31, |
||||||||||||
2020 |
||||||||||||
Consolidated Statements of Cash Flows: |
As Reported |
Adjustments |
As Restated |
|||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||
Provision for unrecoverable advances |
$ | $ | $ | |||||||||
Changes in operating assets and liabilities: |
||||||||||||
Prepaid income taxes |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Income taxes payable |
$ | ( |
) | $ | $ | ( |
) | |||||
Other non-current liabilities |
$ | $ | ( |
) | $ |
For the year ended December 31, |
||||||||||||
2020 |
||||||||||||
Consolidated Statement of Convertible Preferred Stock and Stockholder’s Deficit: |
As Reported |
Adjustments |
As Restated |
|||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total stockholders’ deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
For the year ended December 31, |
||||||||||||
2019 |
||||||||||||
Consolidated Statement of Operations |
As Reported |
Adjustments |
As Restated |
|||||||||
Provision for unrecoverable advances |
$ | $ | $ | |||||||||
Total operating expenses |
$ | $ | $ | |||||||||
Net income (loss) before provision for income taxes |
$ | $ | ( |
) | $ | |||||||
Provision for income taxes |
$ | $ | ( |
) | $ | |||||||
Net income (loss) |
$ | $ | ( |
) | $ |
As of December 31, |
||||||||||||
2019 |
||||||||||||
Consolidated Balance Sheet: |
As Reported |
Adjustments |
As Restated |
|||||||||
Assets |
||||||||||||
Member advances, net of allowance for unrecoverable advances |
$ | $ | ( |
) | $ | |||||||
Total current assets |
$ | $ | ( |
) | $ | |||||||
Total assets |
$ | $ | ( |
) | $ | |||||||
Income taxes payable |
$ | $ | ( |
) | $ | |||||||
Total current liabilities |
$ | $ | ( |
) | $ | |||||||
Total liabilities |
$ | $ | ( |
) | $ | |||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total stockholders’ deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total liabilities, convertible preferred stock, and stockholders’ deficit |
$ | $ | ( |
) | $ |
For the year ended December 31, |
||||||||||||
2019 |
||||||||||||
Consolidated Statements of Cash Flows: |
As Reported |
Adjustments |
As Restated |
|||||||||
Net income |
$ | $ | ( |
) | $ | |||||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||||||
Provision for unrecoverable advances |
$ | $ | $ |
For the year ended December 31, |
||||||||||||
2019 |
||||||||||||
Consolidated Statement of Convertible Preferred Stock and Stockholder’s Deficit: |
As Reported |
Adjustments |
As Restated |
|||||||||
Net income |
$ | $ | ( |
) | $ | |||||||
Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Total stockholders’ deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
December 31, 2020 |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||
Assets |
||||||||||||||||
Marketable securities |
$ | $ | $ | $ | ||||||||||||
Derivative asset on loans to stockholders |
||||||||||||||||
Total assets |
$ |
$ |
$ |
$ |
||||||||||||
December 31, 2019 |
Level 1 |
Level 2 |
Level 3 |
Total |
||||||||||||
Assets |
||||||||||||||||
Marketable securities |
$ | $ | $ | $ | ||||||||||||
Derivative asset on loans to stockholders |
||||||||||||||||
Total assets |
$ |
$ |
$ |
$ |
||||||||||||
Opening value at January 1, 2019 |
$ |
|||
Change in fair value during the period |
||||
Conversion into Series B-2 preferred stock |
( |
) | ||
Ending value at December 31, 2019 |
$ |
|||
Unobservable Inputs |
Range | |
Term (in years) |
||
Calibrated risk premium |
||
Option adjusted spread |
||
Risk-free rate |
Opening value at January 1, 2019 |
$ |
|||
Initial fair value at the original issuance dates |
||||
Change in fair value during the period |
||||
Ending value at December 31, 2019 |
$ |
|||
Change in fair value during the period |
||||
Ending value at December 31, 2020 |
$ |
|||
Expected volatility |
||
Risk-free interest rate |
||
Remaining term |
• | Historical financial performance; |
• | The Company’s business strategy; |
• | Industry information, such as external market conditions and trends; |
• | Lack of marketability of the Common Stock; |
• | Likelihood of achieving a liquidity event, such as an initial public offering, special-purpose acquisition company (“SPAC”) merger, or strategic sale given prevailing market conditions and the nature and history of the Company’s business; |
• | Prices, privileges, powers, preferences and rights of the Company’s convertible preferred stock relative to those of the Common Stock; |
• | Forecasted cash flow projections for the Company; |
• | Illiquidity of stock-based awards involving securities in a private company; and |
• | Macroeconomic conditions. |
For the Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Numerator |
||||||||
Net (loss) income |
$ | ( |
) | $ | ||||
Less: noncumulative dividend to convertible preferred stockholders |
( |
) | ||||||
Net (loss) income attributed to common stockholders—Basic |
( |
) | ||||||
Add back: undistributed earnings allocated to noncumulative dividend to convertible preferred stockholders |
||||||||
Less: non-cumulative dividend to convertible preferred stockholders |
( |
) | ||||||
Net (loss) income attributed to common stockholders—Diluted |
( |
) | ||||||
Denominator |
||||||||
Weighted average shares of common stock—basic |
||||||||
Dilutive effect of equity incentive awards |
||||||||
Dilutive effect of Series A convertible stock |
||||||||
Dilutive effect of Series B-2 convertible stock |
||||||||
Weighted average shares of common stock—diluted |
||||||||
Net (loss) income per share |
||||||||
Basic |
$ | ( |
) | $ | ||||
Diluted |
$ | ( |
) | $ |
For the Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Equity incentive awards |
||||||||
Convertible preferred stock |
||||||||
Total |
||||||||
As of December 31, |
||||||||
2020 |
2019 |
|||||||
Marketable securities |
$ | $ | ||||||
Totals |
$ |
$ |
||||||
Days From Origination |
Gross Member Advances |
Allowance for Unrecoverable Advances |
Member Advances, Net |
|||||||||
1-10 |
$ | $ | ( |
) | $ | |||||||
11-30 |
( |
) | ||||||||||
31-60 |
( |
) | ||||||||||
61-90 |
( |
) | ||||||||||
91-120 |
( |
) | ||||||||||
Total |
$ |
$ |
( |
) |
$ |
|||||||
Days From Origination |
Gross Member Advances |
Allowance for Unrecoverable Advances |
Member Advances, Net |
|||||||||
1-10 |
$ | $ | ( |
) | $ | |||||||
11-30 |
( |
) | ||||||||||
31-60 |
( |
) | ||||||||||
61-90 |
( |
) | ||||||||||
91-120 |
( |
) | ||||||||||
Total |
$ |
$ |
( |
) |
$ |
|||||||
Opening allowance balance at January 1, 2019 |
$ |
|||
Plus: provision for unrecoverable advances |
||||
Less: amounts written-off |
( |
) | ||
Ending allowance balance at December 31, 2019 |
||||
Plus: provision for unrecoverable advances |
||||
Less: amounts written-off |
( |
) | ||
Ending allowance balance at December 31, 2020 |
$ |
|||
December 31, 2020 |
December 31, 2019 |
|||||||
Accrued charitable contributions |
$ | $ | ||||||
Accrued compensation |
||||||||
Sales tax payable |
||||||||
Other |
||||||||
Total |
$ |
$ |
||||||
December 31, 2020 |
December 31, 2019 |
|||||||
Computer equipment |
$ | $ | ||||||
Leasehold improvements |
||||||||
Furniture and fixtures |
||||||||
Total property and equipment |
||||||||
Less: Accumulated depreciation |
( |
) | ( |
) | ||||
Property and equipment, net |
$ |
$ |
||||||
December 31, 2020 |
December 31, 2019 |
|||||||
Internally developed software |
$ | $ | ||||||
Domain name |
||||||||
Less: accumulated amortization |
( |
) | ( |
) | ||||
Intangible Assets, net |
$ |
$ |
||||||
December 31, 2020 |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total future amortization |
$ |
|||
Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Contractual interest expense on 2019 Convertible Notes |
$ | $ | ||||||
Contractual interest expense on 2018 Convertible Notes |
||||||||
Amortization of debt discount on 2018 Convertible Notes |
||||||||
Total interest expense |
$ |
$ |
||||||
Effective interest rate for 2019 Convertible Notes |
% | % | ||||||
Effective interest rate for 2018 Convertible Notes |
% |
For the Year Ended December 31, |
||||||||
2020 |
2019 |
|||||||
Operating lease cost |
$ | $ | ||||||
Short-term lease cost |
||||||||
Variable lease cost |
||||||||
Total lease cost |
$ |
$ |
||||||
Other information: |
||||||||
Cash paid for operating leases |
$ | $ | ||||||
Right-of-use |
$ | $ | ||||||
Weighted-average remaining lease term - operating lease |
||||||||
Weighted-average discount rate - operating lease |
% | % |
Year |
3rd-Party Commitment |
Related-Party Commitment |
Total |
|||||||||
2021 |
$ | $ | $ | |||||||||
2022 |
||||||||||||
2023 |
||||||||||||
2024 |
||||||||||||
2025 |
||||||||||||
Thereafter |
||||||||||||
Total minimum lease payments |
$ |
$ |
$ |
|||||||||
Less: imputed interest |
( |
) | ( |
) | ( |
) | ||||||
Total lease liabilities |
$ |
$ |
$ |
|||||||||
2020 |
2019 |
|||||||
Expected term |
||||||||
Risk-free interest rate |
% | % | ||||||
Expected dividend yield |
% | % | ||||||
Expected volatility |
% | % |
Shares (1) |
Weighted- Average Exercise Price (1) |
Weighted- Average Remaining Contractual Term (years) |
Aggregate Intrinsic Value (in thousands) |
|||||||||||||
Options outstanding, December 31, 2019 |
$ |
$ |
||||||||||||||
Granted |
$ | |||||||||||||||
Exercised |
( |
) | $ | |||||||||||||
Forfeited |
( |
) | $ | |||||||||||||
Expired |
( |
) | $ | |||||||||||||
Options outstanding, December 31, 2020 |
$ | $ | ||||||||||||||
Nonvested options, December 31, 2020 |
$ | $ | ||||||||||||||
Vested and exercisable, December 31, 2020 |
$ | $ | ||||||||||||||
(1) | Prior period results have been adjusted to reflect the ten-for-one |
Shares |
Weighted- Average Grant-Date Fair Value |
|||||||
Nonvested shares at December 31, 2019 |
$ | |||||||
Granted |
$ | |||||||
Vested |
( |
) | $ | |||||
Forfeited |
( |
) | $ | |||||
Nonvested shares at December 31, 2020 |
$ | |||||||
Shares |
Weighted- Average Grant-Date Fair Value |
|||||||
Nonvested shares at December 31, 2019 |
$ | |||||||
Granted |
||||||||
Vested |
( |
) | ||||||
Forfeited |
||||||||
Nonvested shares at December 31, 2020 |
$ | |||||||
Year |
Related-Party Commitment |
|||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total minimum lease payments |
$ |
|||
Less: imputed interest |
( |
) | ||
Total lease liabilities |
$ |
|||
2020 |
2019 |
|||||||
Current: |
||||||||
Federal |
$ | $ | ||||||
State |
||||||||
Total current |
||||||||
Deferred: |
||||||||
Federal |
||||||||
State |
||||||||
Total deferred |
||||||||
Provision for income taxes |
$ |
$ |
||||||
2020 |
2019 |
|||||||
Federal statutory tax rate |
% | % | ||||||
State taxes, net of federal benefit |
% | - 1.5 |
% | |||||
Permanent items—derivative liability |
% | - 4.8 |
% | |||||
Permanent items—stock-based compensation |
- 4.5 |
% | % | |||||
Permanent items—meals and entertainment |
- 0.1 |
% | % | |||||
Permanent items—penalties |
- 0.5 |
% | % | |||||
Permanent items—other |
- 0.1 |
% | % | |||||
Return to provision |
- 0.3 |
% | % | |||||
Research and development tax credit—federal |
% | - 20.3 |
% | |||||
Uncertain tax provision |
- 1.7 |
% | % | |||||
Change in valuation allowance |
- 25.7 |
% | % | |||||
Effective tax rate |
- |
% |
% | |||||
2020 |
2019 |
|||||||
Deferred tax assets: |
||||||||
Allowance for customer advances |
$ | $ | ||||||
Accrued expenses |
||||||||
Accrued compensation |
||||||||
Lease liability |
||||||||
Research and development tax credit |
||||||||
Other |
||||||||
Total deferred tax assets |
||||||||
Deferred tax liabilities: |
||||||||
Property and equipment |
( |
) | ( |
) | ||||
Right of use asset |
( |
) | ( |
) | ||||
State taxes |
( |
) | ( |
) | ||||
Prepaid expenses |
( |
) | ( |
) | ||||
Total deferred tax liabilities |
( |
) |
( |
) | ||||
Total net deferred tax assets before valuation allowance |
||||||||
Less: valuation allowance |
( |
) |
( |
) | ||||
Total net deferred tax liabilties |
$ |
( |
) |
$ |
( |
) | ||
2020 |
2019 |
|||||||
Balance at beginning of year |
$ | $ | ||||||
Increases to prior positions |
||||||||
Decreases to prior positions |
||||||||
Increases for current year positions |
||||||||
Balance at end of year |
$ |
$ |
||||||
Amount |
||||
SEC registration fee |
$ | 290,266 | ||
Legal fees and expenses |
* | |||
Accounting fees and expenses |
* | |||
Miscellaneous |
* | |||
|
|
|||
Total |
$ | * | ||
|
|
* | These fees are calculated based on the securities offered and the number of issuances and accordingly cannot be defined at this time. |
(a) | A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation) by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person’s conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the person did not act in good faith and in a manner which the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the person’s conduct was unlawful. |
(b) | A corporation shall have power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys’ fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which |
such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. |
(c) | (1) To the extent that a present or former director or officer of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a) and (b) of this section, or in defense of any claim, issue or matter therein, such person shall be indemnified against expenses (including attorneys’ fees) actually and reasonably incurred by such person in connection therewith. For indemnification with respect to any act or omission occurring after December 31, 2020, references to “officer” for purposes of this paragraphs (c)(1) and (2) of this section shall mean only a person who at the time of such act or omission is deemed to have consented to service by the delivery of process to the registered agent of the corporation pursuant to § 3114(b) of Title 10 (for purposes of this sentence only, treating residents of this State as if they were nonresidents to apply § 3114(b) of Title 10 to this sentence). (2) The corporation may indemnify any other person who is not a present or former director or officer of the corporation against expenses (including attorneys’ fees) actually and reasonably incurred by such person to the extent he or she has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a) and (b) of this section, or in defense of any claim, issue or matter therein. |
(d) | Any indemnification under subsections (a) and (b) of this section (unless ordered by a court) shall be made by the corporation only as authorized in the specific case upon a determination that indemnification of the present or former director, officer, employee or agent is proper in the circumstances because the person has met the applicable standard of conduct set forth in subsections (a) and (b) of this section. Such determination shall be made, with respect to a person who is a director or officer at the time of such determination, |
(1) | by a majority vote of the directors who are not parties to such action, suit or proceeding, even though less than a quorum, or |
(2) | by a committee of such directors designated by majority vote of such directors, even though less than a quorum, or |
(3) | if there are no such directors, or if such directors so direct, by independent legal counsel in a written opinion, or |
(4) | by the stockholders. |
(e) | Expenses (including attorneys’ fees) incurred by an officer or director in defending any civil, criminal, administrative or investigative action, suit or proceeding may be paid by the corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall ultimately be determined that such person is not entitled to be indemnified by the corporation as authorized in this section. Such expenses (including attorneys’ fees) incurred by former officers and directors or other employees and agents may be so paid upon such terms and conditions, if any, as the corporation deems appropriate. |
(f) | The indemnification and advancement of expenses provided by, or granted pursuant to, the other subsections of this section shall not be deemed exclusive of any other rights to which those seeking indemnification or advancement of expenses may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise, both as to action in such person’s official capacity and as to action in another capacity while holding such office. A right to indemnification or to advancement of expenses arising under a provision of the certificate of incorporation or a bylaw shall not be eliminated or impaired by an amendment to such provision after the occurrence of the act or omission that is the subject of the civil, criminal, administrative or investigative action, suit or proceeding for which indemnification or advancement of expenses is sought, unless the provision in |
effect at the time of such act or omission explicitly authorizes such elimination or impairment after such action or omission has occurred. |
(g) | A corporation shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person’s status as such, whether or not the corporation would have the power to indemnify such person against such liability under this section. |
(h) | For purposes of this section, references to “the corporation” shall include, in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the same position under this section with respect to the resulting or surviving corporation as such person would have with respect to such constituent corporation if its separate existence had continued. |
(i) | For purposes of this section, references to “other enterprises” shall include employee benefit plans; references to “fines” shall include any excise taxes assessed on a person with respect to any employee benefit plan; and references to “serving at the request of the corporation” shall include any service as a director, officer, employee or agent of the corporation which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner “not opposed to the best interests of the corporation” as referred to in this section. |
(j) | The indemnification and advancement of expenses provided by, or granted pursuant to, this section shall, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person. |
(k) | The Court of Chancery is hereby vested with exclusive jurisdiction to hear and determine all actions for advancement of expenses or indemnification brought under this section or under any by law, agreement, vote of stockholders or disinterested directors, or otherwise. The Court of Chancery may summarily determine a corporation’s obligation to advance expenses (including attorneys’ fees). |
Exhibit No. |
Description | |
21.1 | List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Company’s Current Report on Form 8-K filed with the Commission on January 11, 2022). | |
23.1 | Consent of WithumSmith+Brown, PC. | |
23.2 | Consent of Moss Adams LLP. | |
23.3 | Consent of Orrick, Herrington & Sutcliffe LLP (included in Exhibit 5.1). | |
24.1 | Power of attorney (included on the signature page hereof). | |
101.INS | XBRL Instance Document. | |
101.SCH | XBRL Taxonomy Extension Schema Document. | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document. | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. | |
107 | Filing Fee Table. |
* | The schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The Company agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon its request. |
† | Indicates a management contract or compensatory plan, contract or arrangement. |
(a) | The undersigned registrant hereby undertakes: |
(1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
(i) | To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; |
(2) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(4) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
(5) | That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
(b) | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue. |
DAVE INC. | ||
By: | /s/ Jason Wilk | |
Jason Wilk | ||
Title: Chief Executive Officer |
Signature |
Title |
Date | ||
/s/ Jason Wilk Jason Wilk |
Chief Executive Officer and Director ( Principal Executive Officer |
February 2, 2022 | ||
/s/ Kyle Beilman Kyle Beilman |
Chief Financial Officer ( Principal Financial and Accounting Officer |
February 2, 2022 | ||
/s/ Brendan Carroll Brendan Carroll |
Director |
February 2, 2022 | ||
/s/ Andrea Mitchell Andrea Mitchell |
Director |
February 2, 2022 | ||
Michael Pope |
Director |
|||
/s/ Dan Preston Dan Preston |
Director |
February 2, 2022 |